US10793327B2 - Lyophilization container and method of using same - Google Patents
Lyophilization container and method of using same Download PDFInfo
- Publication number
- US10793327B2 US10793327B2 US16/154,976 US201816154976A US10793327B2 US 10793327 B2 US10793327 B2 US 10793327B2 US 201816154976 A US201816154976 A US 201816154976A US 10793327 B2 US10793327 B2 US 10793327B2
- Authority
- US
- United States
- Prior art keywords
- container
- breathable
- breathable section
- section
- lyophilization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004108 freeze drying Methods 0.000 title claims abstract description 100
- 238000000034 method Methods 0.000 title claims abstract description 33
- 239000012528 membrane Substances 0.000 claims abstract description 57
- 239000012530 fluid Substances 0.000 claims abstract description 45
- 238000007710 freezing Methods 0.000 claims abstract description 11
- 230000008014 freezing Effects 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims description 60
- 239000007789 gas Substances 0.000 claims description 19
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 8
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 8
- -1 polyethylene Polymers 0.000 claims description 7
- 239000004743 Polypropylene Substances 0.000 claims description 6
- 229920001155 polypropylene Polymers 0.000 claims description 6
- 239000012779 reinforcing material Substances 0.000 claims description 6
- 239000004698 Polyethylene Substances 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 5
- 239000011261 inert gas Substances 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- 230000000007 visual effect Effects 0.000 claims description 4
- 229920001684 low density polyethylene Polymers 0.000 claims description 3
- 239000004702 low-density polyethylene Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 claims description 2
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract description 24
- 239000007787 solid Substances 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 239000011800 void material Substances 0.000 description 16
- 210000002381 plasma Anatomy 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 239000010836 blood and blood product Substances 0.000 description 12
- 230000037361 pathway Effects 0.000 description 10
- 238000003860 storage Methods 0.000 description 10
- 238000000859 sublimation Methods 0.000 description 9
- 230000008022 sublimation Effects 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 229940125691 blood product Drugs 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 238000003032 molecular docking Methods 0.000 description 8
- 239000012611 container material Substances 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 238000003795 desorption Methods 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 238000011049 filling Methods 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000007789 sealing Methods 0.000 description 6
- 229920002725 thermoplastic elastomer Polymers 0.000 description 6
- 238000001802 infusion Methods 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 238000011109 contamination Methods 0.000 description 4
- 239000005038 ethylene vinyl acetate Substances 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000012792 lyophilization process Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 239000004800 polyvinyl chloride Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000009736 wetting Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920006255 plastic film Polymers 0.000 description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 238000011176 pooling Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000005204 segregation Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 239000012808 vapor phase Substances 0.000 description 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 238000002617 apheresis Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000012633 leachable Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005297 material degradation process Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000012384 transportation and delivery Methods 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/24—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes
- B65D51/241—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes provided with freeze-drying means
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
- F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
- F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0236—Mechanical aspects
- A01N1/0263—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving, e.g. cool boxes, blood bags or "straws" for cryopreservation
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0278—Physical preservation processes
- A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0278—Physical preservation processes
- A01N1/0289—Pressure processes, i.e. using a designated change in pressure over time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B25/00—Details of general application not covered by group F26B21/00 or F26B23/00
- F26B25/06—Chambers, containers, or receptacles
- F26B25/063—Movable containers or receptacles, e.g. carts, trolleys, pallet-boxes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
Definitions
- the present application describes a device and related method for lyophilizing (freeze-drying) and storing a fluid.
- the device is a continually evolving, multi-section lyophilization container that evolves throughout the stages of filling, lyophilization, storage, reconstitution and infusion.
- the method is a means by which the device is manipulated throughout the lyophilization process.
- lyophilization of the fluid occurs in situ within the multi-section lyophilization container.
- Any suitable fluid may be lyophilized and stored using the devices and techniques described in this disclosure, including human and animal blood and related blood products, such as blood plasma.
- a yet further challenge specific to techniques utilizing a flexible container including a breathable membrane, is a limitation in vapor flow caused by a wetting and fouling (i.e., blocking) of the breathable membrane throughout the lyophilization process which leads to relatively slow lyophilization times.
- current devices include an arrangement of breathable and non-breathable elements which fails to provide adequate total breathable surface area, resulting in underperformance.
- a lyophilized blood product such as plasma
- a lyophilized blood product may have much smaller mass than a traditional product, has a longer shelf life and does not require extensive cold chain management or lengthy thawing procedures.
- a lyophilized blood product can be easily and rapidly reconstituted at its point of use, a lyophilized blood product is often preferable in battlefield environments, in emergency response situations and in various clinical applications. For these and other reasons, there remains a need to improve current lyophilization devices and techniques in relation to blood and blood products.
- Embodiments provide for a multi-part lyophilization container.
- the container includes a front surface, a back surface, a non-breathable section including a port region, a breathable section including a breathable membrane, and an occlusion zone encompassing a boundary bridging the non-breathable section and the breathable section.
- the non-breathable section is configured to accommodate any of a liquid, a solid and a gas, whereas the breathable section is configured to accommodate only a gas.
- a method of lyophilizing a fluid in a multi-part container includes creating a temporary seal dividing a non-breathable section of the container and a breathable section of the container, inputting a liquid into the non-breathable section of the container, freezing the liquid, opening the temporary seal to allow vapor flow between the non-breathable section of the container and the breathable section of the container, and adding heat energy to the frozen liquid under vacuum, wherein the breathable section is configured to accommodate only a gas.
- the fluid may be any suitable liquid, including human or animal plasma.
- FIGS. 1A and 1B are plan and perspective views of a lyophilization container according to an embodiment of the present application
- FIGS. 2A and 2B are plan and perspective views of another lyophilization container according to an embodiment of the present application.
- FIG. 3A is a plan view of a non-breathable section of a lyophilization container according to an embodiment of the present application
- FIG. 3B is an expanded view of the port region of the non-breathable section of the lyophilization container of FIG. 3A ;
- FIG. 4 is a plan view of a breathable section of a lyophilization container according to an embodiment of the present application
- FIG. 5 is a section view of the Hold Open Device (HOD) of the breathable section of the lyophilization container of FIG. 4 ;
- HOD Hold Open Device
- FIG. 6 is an expanded view of the HOD capture void of the breathable section of the lyophilization container of FIG. 4 ;
- FIG. 7 is a side section view of an alternative configuration of an occlusion zone according to an embodiment of the present application.
- FIG. 8 is a workflow schematic illustrating an intermittent occlusion of a lyophilization container according to an embodiment of the present application.
- FIG. 9 is workflow schematic illustrating an intermittent occlusion of a lyophilization container according to another embodiment of the present application.
- Embodiments of the present application refer to a closed, sterile container, including sterile fluid pathways, for lyophilizing and storing a fluid, thus obviating the need for a clean room.
- embodiments described in this application may be implemented in conjunction with many conventional, commercially available lyophilizers, such as the EPIC Small Production Lyophilizer by Millrock Technology. Accordingly, the devices and techniques described in this application may be more widely distributed and widely accessible than are existing devices and techniques. Further advantages of the various enumerated embodiments are noted throughout this disclosure.
- multi-part container “container,” “lyophilization container,” “multi-part lyophilization container,” and the like, are used interchangeably throughout this disclosure.
- breathable with respect to materials and membranes, may be used interchangeably with the term “semi-permeable.”
- non-breathable may be used interchangeably with the term “non-permeable.”
- FIGS. 1A and 1B are plan and perspective views of a lyophilization container according to an embodiment of the present application.
- the lyophilization container 100 includes a non-breathable section 102 , including a port region 104 ; a breathable section 106 , including a breathable membrane 108 and an inner membrane weld 110 ; an outer perimeter weld 112 ; and an occlusion zone 114 .
- the lyophilization container 100 is essentially rectangular and is comprised of two principal sections: non-breathable section 102 and breathable section 106 , joined in occlusion zone 114 .
- Non-breathable section 102 and breathable section 106 are in communication with one another in a native or normal state, and together encapsulate the container cavity.
- Port region 104 defines an area within non-breathable section 102 that is configured to incorporate one or more fluidic ports.
- Breathable membrane 108 is incorporated into breathable section 106 by inner membrane weld 110 , which is a sterile seal.
- Outer perimeter weld 112 is also a sterile seal and defines the outer perimeter of the lyophilization container 100 , including the port region 104 .
- the overall length of the lyophilization container 100 is approximately 50 cm.
- L may be any dimension suitable for placement of the container in a shelf lyophilizer or other lyophilizer, any dimension required to increase or decrease vapor flow resistance, or any dimension to increase or decrease the thickness of the frozen liquid, such as between 30 cm and 70 cm, or more preferably between 40 cm and 60 cm.
- the width of the container, denoted as “W,” is approximately 15 cm. In embodiments, W may any suitable dimension, such as between 10 cm and 20 cm, or more preferably, between 13 cm and 17 cm.
- the length of non-breathable section 106 measured from the midpoint of the occlusion zone, is approximately 28 cm. In embodiments, the length of non-breathable section 106 may any suitable dimension, such as between 20 cm and 40 cm, or more preferably, between 24 cm and 32 cm. The length of breathable section 102 , measured from the midpoint of the occlusion zone, is approximately 22 cm. In embodiments, the length of breathable section 106 may any suitable dimension, such as between 10 cm and 30 cm, or more preferably, between 18 cm and 26 cm. The exemplary dimensions of 15 cm by 50 cm described above are suited to lyophilize approximately 300 ml of liquid plasma. The lyophilization of larger or smaller volumes would suggest different preferred dimensions.
- FIGS. 1A and 1B depict an essentially rectangular container
- some embodiments might include geometries that deviate from the rectangular shape.
- the width of only occlusion zone 114 might be reduced to less than the width W of the embodiment shown.
- Such an adjustment may result in an essentially hourglass shaped container as opposed to a container having a rectangular shape. This type of adjustment in occlusion zone 114
- dimension may better facilitate temporarily sealing of the occlusion zone during the lyophilization process.
- the “top” or “front” of the lyophilization container 100 shown is essentially identical to the “bottom” or “back” of the container 100 . That is, each of the top and the bottom of the container includes non-breathable material of the non-breathable section and breathable membrane of the breathable section.
- the breathable membrane comprises a continuous sheet including an isoclinal (i.e., hairpin) fold causing the breathable membrane to bridge a portion of the top or front surface and a portion of the bottom or back surface.
- the breathable section might comprise breathable membrane only on the top of the container or only on the bottom of the container.
- the lyophilization container 100 is typically placed on a lyophilizer shelf such that the bottom or back of the container faces the lyophilizer shelf. That is, during lyophilization, a portion of each of the non-breathable section 102 and the breathable section 106 , including breathable membrane, face the lyophilizer shelf.
- Non-breathable section 102 should be in sufficient direct or indirect thermal communication with the lyophilizer shelf to facilitate conductive and/or radiative heat transfer.
- only the non-breathable section might be in contact with the shelf and the breathable section might reside off the shelf.
- the lyophilization container may be disposed vertically within a lyophilization chamber.
- lyophilization container 100 exchanges fluids via ports positioned in the port region 104 of non-breathable section 102 . Fluid exchanges occur only during initial filling of the container with liquid plasma and during the post-lyophilization filling of the container with sterile water for reconstitution and transfusion into a patient. Both prior to, and after, the sublimation of the frozen fluid and removal of vapor during lyophilization, non-breathable section 102 and breathable section 106 are isolated from one another by a creation of an occlusion of the container in the occlusion zone 114 encompassing the transition between the non-breathable section 102 and breathable section 106 . In this respect, the position of the occlusion within the occlusion zone 114 defines the boundary between non-breathable section 102 and breathable section 106 .
- Outer perimeter weld 112 defines the outer perimeter of the container and includes port region 104 of the non-breathable section 102 .
- Outer perimeter weld 112 has an average width of approximately 7 mm. In embodiments; however, outer perimeter weld 112 may be any suitable width, such as between 2 mm and 12 mm, and may further be variable by up 3 mm along its length.
- Inner membrane weld 110 surrounds the breathable membrane 108 within breathable section 106 .
- Inner membrane weld 110 also has average width of approximately 7 mm; however, in embodiments, inner membrane weld 110 may be any suitable width, such as between 2 mm and 12 mm, variable by up 3 mm along its length.
- Port region 104 is the portion of the outer perimeter weld 112 of non-breathable section 102 configured to incorporate one or more fluidic ports capable of forming a sterile fluid pathway between the lyophilization container and any of several other fluid containers. Port region 104 is also configured to facilitate transfusion to a patient.
- occlusion zone 114 is adapted to facilitate the evolution of the container throughout its life cycle. Occlusion of the container 100 in the occlusion zone 114 creates a temporary impermeable or substantially impermeable seal, eliminating the fluid communication between the non-breathable section 102 and breathable section 106 .
- an initial occlusion isolates non-breathable section 102 from the breathable section 106 prior to the introduction of fluid via ports in port region 104 . Removal or opening of the occlusion upon formation of a frozen ice structure (i.e., a frozen fluid structure to be lyophilized) allows the container to resume its native state, thus restoring the original container cavity.
- the container again provides a generous, open pathway for vapor flow between the non-breathable section 102 and breathable section 106 .
- the ability of the container to continually evolve in form and function ensures that no contact occurs between the subject fluid and the breathable section 106 by causing the subject liquid to be isolated and frozen in only the non-breathable section 106 and allowing only the vapor flow from sublimation and desorption to contact the breathable section 106 . That is, embodiments of the present application are configured to create a continuous physical separation between the subject liquid and the breathable section 106 .
- the non-breathable section 102 is adapted to accommodate any of a solid, a liquid or a gas
- the breathable section 106 is adapted to accommodate only a gas (i.e., a gas only section).
- Occlusion zone 114 is approximately 3 cm in width; however, in embodiments, the occlusion zone may be between 1 cm and 5 cm wide, such as between 2 cm and 4 cm wide.
- the nearest edge of the occlusion zone is preferably positioned within 5 cm of the breathable membrane 108 of the breathable section 106 , but may be positioned between 0.2 cm and 10 cm, such as between 3 cm and 7 cm, from the breathable membrane 108 .
- the occlusion zone 114 should be sufficiently proximate to the breathable membrane 108 to ensure the efficient use of container materials and to minimize the distance that vapor must flow to exit the container, yet sufficiently distant from the breathable membrane 108 to allow for the creation of a permanent seam in non-breathable material between the occlusion and the breathable membrane post lyophilization.
- the creation of a permanent seam in non-breathable material between the occlusion and the breathable membrane material post-lyophilization creates a permanent seal, allowing for a permanent separation of container sections and the removal and disposal of the breathable section 106 .
- Removal of the breathable section 106 is the final step in the evolution of the container. Removal of the breathable section 106 minimizes the volume and the mass of the final product, which is desirable for both transportation and storage. Additionally, removal of breathable section 106 transforms non-breathable section 102 into a more traditional container suitable for fluid transfusion into a patient.
- a visual indication may demarcate the occlusion zone 114 .
- the occlusion zone 114 may be indicated by lines, by a color scheme, or by any other conventional means of visual indication.
- a choice of material or texture may indicate the position of the occlusion zone 114 .
- a textured surface may provide a visual position indication designed to indicate the position and boundaries of the occlusion zone 114 .
- particular materials or textures may also be chosen for one, or both, of the inner or outer surfaces of container material in the occlusion zone 114 to provide improved sealing characteristics (e.g., smooth materials), to impart an improved ability of the materials to pull apart from one another, or to pull apart from ice formed during freezing of the subject fluid (e.g., textured materials).
- materials chosen for the occlusion zone 114 may be textured or smooth and may be like or dissimilar to one another.
- Material and design choices for the occlusion zone 114 should consider that an intermittent application and removal of an occlusion in the occlusion zone 114 must reliably result in the intermittent creation and removal of a temporary impermeable seal.
- an occlusion may not be a perfectly impervious or hermetic barrier or seal. That is, in certain situations, minor or insubstantial leakage across an occlusion may be acceptable.
- the creation of an occlusion of the container in the occlusion zone 114 may occur by any known means, such as by manual clamping, or by various automated or semi-automated means.
- Exemplary manual clamps may include, but are not limited to, screw clamps or bag clips that are in common usage.
- Various automated or semi-automated occlusion means may, for example, include mechanical compression means incorporated into the shelves of, or the shelf system of, a lyophilizer. In all cases, the means chosen for creating an occlusion must ensure that fluids input into the non-breathable section 102 via port region 104 do not contact breathable membrane 108 of breathable section 106 at any point.
- non-breathable section 102 various additional features may also be included in non-breathable section 102 .
- a section of relatively clear container material may be incorporated into non-breathable section 102 to allow visual inspection of the subject fluid before, during or after lyophilization.
- the non-breathable material is ethylene-vinyl acetate (EVA).
- EVA ethylene-vinyl acetate
- EVA exhibits several advantageous properties including its relative strength, its relative elasticity and resilience at low temperatures, its relative crack resistance and the ease with which it may be manufactured. EVA also exhibits comparatively favorable thermal transfer properties. Nonetheless, in embodiments, material choices for non-breathable material are not limited, and may include a variety of non-breathable materials that exhibit preferable characteristics, such as thermoplastic elastomers (TPEs). TPEs are relatively soft and flexible, and exhibit advantages for several healthcare applications. For instance, TPEs can be sterilized using autoclaves, gamma irradiation, or ethylene oxide. Further, TPEs can be designed to be biocompatible, to have high purity, and to have low levels of extractable and leachable substances. TPEs are also recyclable and are a comparatively favorable material for cryogenic storage.
- Linear, low density polyethylene may also be desirable for use as non-breathable material.
- LLDPE is preferable to certain other materials due to its favorable puncture and impact resistance and to its high tensile strength. For instance, as compared to LDPE, LLDPE exhibits superior flexibility and resistance to cracking, thus making it more suitable for certain thin film applications.
- non-breathable material Materials selected for non-breathable material must maintain strength at low temperatures (e.g., ⁇ 40° C. to ⁇ 60° C.) as is required for lyophilization. Certain materials exhibiting a low surface energy and super-hydrophobicity may further be incorporated into the interior surface of the non-breathable section to facilitate an improved release of the ice structure from the inner surfaces of the container after freezing and before drying.
- various additional or alternative plastic films may be incorporated into non-breathable section 102 , or to all areas of the container with non-breathable material for a particular purpose or application.
- materials may be implemented for any of improved impermeability, improved heat sealing characteristics or improved mechanical strength.
- FIGS. 2A and 2B are plan and perspective views of another lyophilization container according to an embodiment of the present application.
- the lyophilization container 200 includes a non-breathable section 202 , including a port region 204 ; a breathable section 206 , including a Hold Open Device (HOD) 208 , a breathable membrane 210 ; an inner membrane weld 212 ; an outer perimeter weld 214 ; and an occlusion zone 216 .
- HOD Hold Open Device
- the lyophilization container 200 is essentially the same as the lyophilization container of FIGS. 1A and 1B , further including a Hold Open Device (HOD) 208 .
- HOD 208 is a semi-rigid, flat-sided elliptical fixture, captured within the lyophilization container 200 .
- HOD 208 is in an open mode in its native state, disposed circumferentially within the container cavity to facilitate a pathway for vapor flow between non-breathable section 202 and breathable section 206 .
- HOD 208 is positioned entirely within the breathable section 206 , bridging portions of breathable membrane 210 and non-breathable material.
- HOD 208 shape is not limited, and various alternative HOD 208 designs may be implemented, such as a modified rectangle or other shape capable of facilitating vapor flow between container sections.
- HOD 208 may be a rigid or a semi-rigid fixture captured within, or fastened to the outside of, the breathable section of the lyophilization container 200 .
- the exact position of the HOD 208 may vary.
- the HOD 208 may be positioned entirely within the non-breathable section, or within a region of non-breathable material of the breathable section.
- HOD 208 may extend into portions of both non-breathable material and breathable material.
- HOD 208 may be positioned and configured to assist in the creation of the temporary seal between bag sections.
- HOD 208 is positioned proximate to the occlusion zone to minimize the distance between the HOD 208 and the placement of an occlusion in the occlusion zone 216 .
- the nearest edge of HOD 208 is positioned approximately 2.5 cm from nearest edge of the occlusion zone 216 . Nonetheless, HOD 208 placement may be further optimized according to a particular container 200 or occlusion zone 216 configuration.
- FIG. 3A is a plan view of a non-breathable section of a lyophilization container according to an embodiment of the present application.
- non-breathable section 300 comprises a non-breathable material 302 ; and an outer perimeter weld 304 , including a port region 306 incorporating fluidic ports 308 ; and a portion of an occlusion zone 310 .
- Non-breathable section 300 is comprised of the non-breathable material described above.
- the boundaries of non-breathable section 300 include outer perimeter weld 304 , including port region 306 , and the midpoint (i.e., estimated position of occlusion) of the occlusion zone. That is, when the container is occluded in the occlusion zone 310 , non-breathable section 300 may be defined as the section of the container on the side of the occlusion that is non-breathable. When an occlusion is not present in the occlusion zone 310 , the boundary of the non-breathable section may be approximated as the midpoint of the occlusion zone, as shown ion FIG. 3A .
- FIG. 3B is an expanded view of the port region of the non-breathable section of the lyophilization container of FIG. 3A .
- port region 306 includes three ports 308 .
- the ports 308 define the manner in which the lyophilization container exchanges fluids with other vessels and containers.
- the ports 308 must accordingly provide secure, sterile connections which eliminate the potential for breakage, contamination or misconnection, and must function across every phase of use including filling, lyophilization, storage, reconstitution and, in the case of lyophilized plasma, infusion.
- the configuration and number of ports 308 may vary depending on a particular application. For instance, embodiments may include between 1-5 ports, such as 3 ports. Ports 308 may further include connections which are either resealable or non-resealable.
- Ports 308 shown in FIG. 3B may be adapted to include a variety of ports.
- ports 308 may include any of a spike port, a docking port and a reconstitution port.
- a spike port may be included to facilitate reinfusion of a reconstituted blood product into a patient.
- An exemplary spike port may be any weldable spike port known in the art which is compatible for use in lyophilization containers. Examples of suitable materials for use in spike port include polyvinyl chloride (PVC) and ethylene-vinyl acetate (EVA) (e.g., such as is manufactured by Carmo of Denmark). In other embodiments, a polypropylene (PP) spike port may be desirable.
- PVC polyvinyl chloride
- EVA ethylene-vinyl acetate
- PP polypropylene
- a docking port may be included to connect the lyophilization container with another fluid container, such as a blood pooling container or pooling container set.
- a docking port may further be used to introduce air or other gas into the lyophilization container. Air or other gas may, for example, be introduced to create a vapor space above the subject liquid or to regulate pH.
- An exemplary docking port comprises PVC tubing. In embodiments, however, dock port may include any suitable docking fixtures or tubing which are known in the art.
- a reconstitution port may be included to accept an inflow of reconstitution fluid into the lyophilization container.
- An exemplary reconstitution port 308 may include a male or a female Luer-Lock type connection in order to prevent accidental misconnection.
- One example of such a connection is the Correct Connect® system that is a standardized connection system used in apheresis applications.
- various one-way valves and other means for providing an error proof connection may also be adapted for use with the reconstitution port 308 .
- the type of connection used for reconstitution is particularly important. That is, the handling of reconstitution fluids entails the potential risk of a direct transfusion of the reconstitution fluid into the patient. Such an event constitutes a serious and immediate health hazard. For this reason, it is important that the reconstitution port and related connections be highly conspicuous and be incompatible with the other ports in order to avoid an occurrence of accidental misconnection.
- FIG. 4 is a plan view of a breathable section of a lyophilization container according to an embodiment of the present application.
- breathable section 400 comprises an outer perimeter weld 402 , including a Hold Open Device (HOD) capture void 404 ; a HOD 406 ; a breathable membrane 408 ; an inner membrane weld 410 ; and a portion of an occlusion zone 412 .
- HOD Hold Open Device
- breathable section 400 include outer perimeter weld 402 and the midpoint (i.e., estimated position of occlusion) of the occlusion zone 412 . That is, when the container is occluded in the occlusion zone 412 , breathable section 400 may be defined as the section of the container on the side of the occlusion that is breathable. When an occlusion is not present in the occlusion zone 412 , the boundary of the breathable section 400 may be approximated as the midpoint of the occlusion zone, as shown in FIG. 4 .
- Breathable section 400 comprises breathable membrane 408 embedded within non-breathable material.
- Inner membrane weld 410 is a sterile seal defining the boundary between the breathable membrane and non-breathable material.
- Outer perimeter weld 402 is a sterile seal defining the outer perimeter of breathable section 400 .
- Outer perimeter weld 402 includes HOD capture voids 404 for capturing HOD 406 within the container.
- breathable membrane 408 may comprise only one material.
- breathable membrane 408 may comprise two or more materials, for example, breathable membrane may comprise a membrane laminate consisting of a breathable membrane and a backing material.
- membrane material may include an expanded polytetrafluoroethylene (PTFE).
- PTFE membranes are preferable to other membranes for several reasons. For instance, expanded PTFE provides a microstructure that may be precisely controlled, which results in the ability to obtain a desired a pore size distribution. Further, expanded PTFE is essentially inert, is operable across a large temperature range and can withstand harsh environments. For at least these reasons, expanded PTFE provides characteristics which are preferable in comparison to other materials.
- An ideal pore size for an expanded PTFE membrane may be between 0.1 micron ( ⁇ m) to 0.5 ⁇ m, such as 0.15 ⁇ m to 0.45 ⁇ m, or 0.2 ⁇ m to 0.3 ⁇ m.
- a PTFE membrane having pore sizes in this range exhibits relatively efficient vapor transmission characteristics while maintaining a sterile barrier capable of eliminating the ingress of contaminants.
- a reinforcing material is designed to bond the breathable section 400 to the non-breathable section without impairing the functionality of the breathable membrane 406 .
- the addition of a reinforcing material improves the structural integrity of the container. That is, the reinforcing material must bond with the breathable membrane, must bond with the non-breathable material, and must have a pore size that does not impede vapor transmission across the breathable membrane during lyophilization.
- Exemplary reinforcing materials are preferably a 50:50 polypropylene/polyethylene blend. In embodiments, however, preferable blend ratios may vary and may be between 40:60 and 60:40 polypropylene:polyethylene.
- Polypropylene backing materials are advantageous, inter alia, for their transition glass temperatures which are low enough to avoid material degradation during freezing at lyophilization temperatures, such as ⁇ 40° C.
- various additional or alternative plastic films may be incorporated into the breathable membrane or to the backing material to impart desired characteristics, such as favorable heat sealing characteristics, improved permeability, or for overall mechanical strength.
- FIG. 5 is a section view of the Hold Open Device (HOD) of the embodiment shown in FIG. 4 .
- HOD Hold Open Device
- HOD 500 is a semi-rigid fixture having an essentially ovular or elliptic shape incorporating pointed ends and flat sides.
- HOD 500 is captured within the breathable section proximate to the occlusion zone.
- the HOD 500 may be coupled to the outside of the container.
- the HOD 500 is designed to reside in, or on the outside of, the breathable section of the container, physically separated from the subject liquid throughout the container life cycle, various further embodiments could include HOD 500 in the non-breathable section.
- Incorporation of the elliptic HOD 500 creates a generous open region above a thin, uniform structure of ice.
- the thin, uniform ice structure has a thickness of from 6 mm to 13 mm, such as 10 mm, to maximize the efficacy and efficiency of the container.
- Incorporating the HOD 500 assists in securing a generous vapor pathway between the non-breathable section and the breathable section and reduces overall vapor pressure in the container during sublimation.
- HOD 500 may also compliment the intermittent creation of occlusions (i.e., temporary impermeable or substantially impermeable seals) in the occlusion zone.
- HOD 500 may impart a tautness to container material which improves the reliability or quality of an occlusion.
- HOD 500 may likewise assist in the pulling apart of occlusion zone surfaces throughout the removal of the occlusion, thereby facilitating a re-creation of the vapor pathway between container sections.
- the pulling apart of occlusion zone surfaces can be complicated by the existence of ice formed on, or directly adjacent to, the occlusion as a result of an inadvertent wetting of occlusion zone materials by the subject fluid prior to the freezing step. Such wetting may be caused during the filling step, or by movement of the container.
- HOD may compliment other means employed to address problems associated with the pulling apart of occlusion zone surfaces described herein, including material and related texture choices.
- HOD 500 comprises a semi-rigid silicone.
- several other rigid or semi-rigid materials may be implemented.
- PVC or certain other synthetic plastic polymers may be preferable HOD 500 material.
- semi-rigid materials may be incorporated for their ability to flex in response to an occlusion of the occlusion zone.
- HOD may compress to some degree upon occlusion of the occlusion zone, and may rebound toward an original shape upon removal of the occlusion.
- shape-memory behavior may assist in the maintaining of an open region above the subject liquid or ice and in the creation of generous vapor pathway between container sections. This may be especially pronounced in embodiments combining a semi-rigid HOD with other flexible container materials.
- the external height of HOD 500 shown in FIG. 5 is 2.8 cm; however, in embodiments, external height may vary from 1.5 cm to 4 cm.
- the internal height is approximately 2.2 mm; however, in embodiments, the internal height may vary between 1 cm to 3 cm depending on the exact configuration and size of HOD.
- HOD width is the approximate width of the lyophilization container.
- HOD 500 depth is approximately 3.5 cm; however, in embodiments HOD depth may be between 0.5 cm and 4 cm.
- the overall size and shape of HOD 500 is not limited, and accordingly may vary depending on the desired configuration of a particular embodiment.
- FIG. 6 is an expanded view of the Hold Open Device (HOD) capture void of the breathable section of the lyophilization container of FIG. 4 .
- HOD Hold Open Device
- HOD capture void 600 includes a void space 602 , sidewalls 604 and outer perimeter weld 606 .
- HOD capture void 600 is essentially an indentation or a void within outer perimeter weld 606 in which the HOD is securely captured. As shown, the void space 602 has a width which is slightly larger than the width of the HOD to accommodate the HOD. Sidewalls 604 are angled at approximately 45 degrees to the longitudinal axis of the outer perimeter weld. Void space 602 depth is approximately 4 mm.
- each of the parameters of the HOD capture void 600 can be optimized.
- HOD void space 602 width may vary according to a particular container configuration and may be as much as 20 percent greater than the width of the HOD.
- HOD void space 602 depth may vary.
- HOD void space 602 depth may be between 1 mm and 6 mm, such as between 2 mm and 4 mm.
- HOD capture void 600 may also vary.
- sidewall 604 angle may be lesser or greater than 45 degrees.
- the sidewalls 604 may be perpendicular to the longitudinal axis of the outer perimeter weld 606 .
- sidewall 604 angles may be dissimilar.
- HOD void space 602 depth may vary along its length. That is, in embodiments, HOD capture void 600 may be asymmetrical or irregular.
- FIG. 7 is a side section view of an alternative configuration of an occlusion zone according to an embodiment of the present application.
- occlusion zone 700 includes top material 702 ; dam 704 ; and a liquid 706 .
- occlusion zone 700 is incorporated into a lyophilization container disposed horizontally on a lyophilizer shelf.
- Top material 702 of occlusion zone 700 comprises non-breathable material and is positioned opposite the container cavity from dam 704 .
- Dam 704 is a rigid or semi-rigid container feature capable of maintaining a segregation of the liquid 706 input to the non-breathable section.
- Dam 704 height measured from the shelf of the lyophilizer can be any height which exceeds the height of liquid input into non-breathable section. In this respect, dam 704 prohibits the flow of fluid from non-breathable section into breathable section, as shown in FIG. 7 .
- Dam 704 shown in FIG. 7 comprises a dome shape; however, in embodiments, other dam designs may be desirable. For instance, dam designs including a flat top, or dam designs configured to cooperate with a particular occlusion device or member (not shown) may be desirable. Similarly, textured materials may be included in dam designs to assist in the creation of a temporary impermeable seal during occlusion. In yet further embodiments, dam features may be incorporated into a lyophilization container designed to hang vertically. In embodiments, a dam may be included on one or both sides of an occlusion zone to maintain a segregation of the fluid input into the non-breathable section.
- lyophilization container(s) described herein are configured to continually evolve as the lyophilization process moves through its cycle.
- Exemplary workflows included below describe the manner in which container embodiments may be manipulated to accomplish container evolution.
- FIG. 8 is a workflow schematic illustrating an intermittent occlusion of a lyophilization container according to an embodiment of the present application.
- an occlusion is created in the occlusion zone.
- a subject fluid e.g., blood plasma
- a port in the port region e.g., a docking port.
- the liquid in the container is frozen, creating a thin, uniformly thick structure of ice in the non-breathable section.
- the occlusion is removed (i.e., the temporary seal is opened) from the occlusion zone.
- vacuum and heat energy are applied to accomplish sublimation and desorption, causing a phase change in the ice structure from the solid phase directly to the vapor phase.
- Vapor released from the ice structure flows through the container cavity via the unoccluded occlusion zone and escapes through the breathable section, leaving the lyophilized plasma cake (i.e., the ice structure now dehydrated as a result of lyophilization) in the non-breathable section.
- the container is again occluded in the occlusion zone to prevent contamination of the lyophilizate with moisture and oxygen from air.
- a permanent seam is created in non-breathable material of the breathable section between the occlusion and the HOD.
- the container is divided at the permanent seam and the breathable section is discarded, leaving the lyophilizate in the non-breathable section which has now evolved into its final form as a medical infusion bag.
- the introduction of fluid may be referred to as pre-loading.
- pre-loading between 250 ml to 500 ml of fluid (e.g., blood plasma) are input into the non-breathable section of the multi-part lyophilization container.
- the container is then placed horizontally on the shelf of a lyophilizer, “front” or “top” side upward facing.
- sublimation and desorption include the application of heat energy and vacuum.
- Preferable drying temperatures may range from ⁇ 20° C. to ⁇ 40° C., such as ⁇ 25° C.
- a diminution in sublimation times as compared to conventional lyophilization techniques is realized.
- embodiments result in reduced vapor pressures in, and an increase in mass transfer across, the breathable section, which may result in a sufficient drying of the ice structure solely during a single drying phase. That is, embodiments may obviate the need for the secondary drying phase of traditional 2-phase drying methods (i.e., desorption).
- step 812 an occlusion is made in the occlusion zone of the container, creating a temporary seal between the breathable section and the non-breathable section.
- step 814 a permanent seam is created, isolating the lyophilized cake in the non-breathable section.
- permanent seam step 814 is a discreet step. That is, an ancillary piece of equipment is used to create the permanent seam or seal.
- permanent seam step 814 may be integrated into occlusion step 812 .
- the occlusion means e.g., a clamp
- the permanent sealing means may incorporate the permanent sealing means.
- step 816 the complete removal of the breathable section represents the final evolution of the container. Removal of the breathable section eliminates the potential for moisture and oxygen ingress into the dried product, thereby increasing shelf life and plasma stability. Additionally, the reduced size of the final lyophilizate container is more convenient for each of transportation, storage, reconstitution and infusion.
- steps may be added to the workflow described in FIG. 8 .
- additional steps may include the introduction of gas into the lyophilization container to regulate pH or to create a vapor space above the subject fluid or ice structure.
- an additional step may include backfilling the lyophilization container with an inert gas to regulate container pressure.
- FIG. 9 is workflow schematic illustrating an intermittent occlusion of a lyophilization container according to another embodiment of the present application.
- an occlusion is created in the occlusion zone.
- a subject fluid e.g., blood plasma
- a port in the port region e.g., a docking port
- air, inert gas, or a pH regulating gas e.g., CO 2
- the liquid in the container is frozen, creating a thin, uniformly thick structure of ice in the non-breathable section.
- the occlusion is removed from the occlusion zone.
- step 912 vacuum and heat energy are applied to accomplish sublimation and desorption, causing a phase change in the ice structure from the solid phase directly to the vapor phase. Vapor released from the ice structure flows through the container cavity via the unoccluded occlusion zone and escapes through the breathable section, leaving the lyophilized plasma cake in the non-breathable section.
- step 914 the container is backfilled with an inert gas to raise container pressure to partial atmospheric pressure.
- step 916 the container is occluded in the occlusion zone to prevent contamination of the lyophilizate.
- a permanent seam is created in the non-breathable material of the breathable section between the occlusion and the HOD.
- step 920 the container is divided at the permanent seam and the breathable section is discarded, leaving the lyophilized end-product in the non-breathable section.
- FIG. 9 essentially represents a departure from the workflow of FIG. 8 only in the addition of steps 906 and 914 .
- air or nitrogen or another inert dry gas, or a pH regulating gas (e.g., CO 2 ) is introduced into the lyophilization container.
- Air can be introduced to create a generous physical separation, i.e., a vapor space, between the container material and the preloaded fluid.
- the introduction of a vapor space may cause container pressure to reach between 0.3 Pound per square inch (Psi) and 1.0 Psi, such as 0.5 Psi (approximately 26 mmHG).
- a pH-regulating gas may be introduced to the lyophilization container to regulate pH.
- a pH-regulating gas might be introduced during step 914 described below.
- the lyophilization container is backfilled to partial atmospheric pressure with pH regulating gas (e.g., CO 2 ).
- pH regulating gas e.g., CO 2
- backfill pressure is 65 Torr (or 65 mmHG) absolute pressure.
- backfill pressure may range from between 40 mmHG and 90 mmHG, such as between 60 mmHG and 70 mmHG.
- the resultant container has been occluded and/or sealed at a pressure that is less than atmospheric pressure, and since final container volume will be in a reduced volume condition once the vacuum of the lyophilizer is removed, the final lyophilized product can be stored and transported more easily. Backfilling in this manner is particularly applicable to container embodiments having flexible materials or components since such a diminution of container volume would not be possible with a rigid, inflexible lyophilization container.
- occlusion means may be integrated into the flexible container, or may be a reusable piece of equipment external to the container.
- occlusion means must be capable of creating a temporary impermeable or substantially impermeable seal between the non-breathable section and the breathable section of the evolving multi-part lyophilization container.
- a physical barrier e.g., a clamp
- Fouling can disrupt the sublimation and desorption aspects of lyophilization, thereby increasing total lyophilization time and reducing the ability to obtain a viable lyophilizate. Accordingly, eliminating the potential for fouling leads to a relative increase in vapor flow which, in turn, results in faster freeze drying, a colder ice temperature during primary drying due to an increased sublimative cooling effect and increased retention of proteins and clotting factors.
- embodiments enable lyophilization to occur in both non-sterile environments and in remote locations.
- embodiments allow lyophilization to be performed on-site at an ordinary blood center as opposed to a traditional clean room facility.
- Container embodiments also allow flexibility for an operator to freeze and maintain a frozen inventory of plasma in a standard freezer, such as that found in typical blood bank settings. At a later time, this previously frozen plasma can be moved to the more specialized lyophilization instrument for sublimation and desorption. Such work flow flexibility results in improved blood logistics and work flow within the blood bank.
- a further advantage of embodiments described herein is the ability to remove the non-breathable section of the lyophilization container post-lyophilization. Isolation and removal of the breathable section post-lyophilization results in the creation of a smaller, lighter aseptic container enclosing the final lyophilizate.
- the resultant container is also both flexible and highly portable.
- the breathable section is most vulnerable to moisture and oxygen ingress, its removal can be said to improve the shelf stability of the lyophilizate.
- the novel use of a temporary occlusion described herein makes this advantage possible. That is, in conventional systems utilizing glass containers, a stopper is mechanically applied to a glass lyophilization container prior to the opening of the lyophilizer in order to prevent an ingress of moisture and oxygen into the container.
- present embodiments utilize the temporary occlusion to prevent an ingress of moisture and oxygen into the non-breathable portion of the container until a permanent seal can be made between non-breathable material portions of the front and back of the container.
- embodiments herein to evolve container configuration, yet to remain a closed, sterile system throughout each phase of container lifecycle is highly unique and advantageous in the lyophilization space. That is, the present embodiments evolve to achieve significant advantages over conventional devices and methods during each of filling, lyophilization, transportation, storage, reconstitution and infusion. Accordingly, many of the attributes and advantages described herein are not possible using conventional devices and approaches, which do not evolve and which require a clean room environment. Importantly in this regard, the evolving, multi-part containers described herein should be further considered evolving, multi-function containers insofar as the type and arrangement of container elements allow the container to accomplish various functions throughout its lifecycle.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Mechanical Engineering (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Drying Of Solid Materials (AREA)
- Bag Frames (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims (28)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/154,976 US10793327B2 (en) | 2017-10-09 | 2018-10-09 | Lyophilization container and method of using same |
US17/010,083 US11634257B2 (en) | 2017-10-09 | 2020-09-02 | Lyophilization container and method of using same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762569858P | 2017-10-09 | 2017-10-09 | |
US201762571087P | 2017-10-11 | 2017-10-11 | |
US16/154,976 US10793327B2 (en) | 2017-10-09 | 2018-10-09 | Lyophilization container and method of using same |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/010,083 Continuation US11634257B2 (en) | 2017-10-09 | 2020-09-02 | Lyophilization container and method of using same |
Publications (2)
Publication Number | Publication Date |
---|---|
US20190106254A1 US20190106254A1 (en) | 2019-04-11 |
US10793327B2 true US10793327B2 (en) | 2020-10-06 |
Family
ID=63966146
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/154,976 Active US10793327B2 (en) | 2017-10-09 | 2018-10-09 | Lyophilization container and method of using same |
US17/010,083 Active US11634257B2 (en) | 2017-10-09 | 2020-09-02 | Lyophilization container and method of using same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/010,083 Active US11634257B2 (en) | 2017-10-09 | 2020-09-02 | Lyophilization container and method of using same |
Country Status (6)
Country | Link |
---|---|
US (2) | US10793327B2 (en) |
EP (1) | EP3694322A1 (en) |
JP (2) | JP7110360B2 (en) |
CN (1) | CN111295094A (en) |
CA (1) | CA3078625C (en) |
WO (1) | WO2019074886A1 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11067336B2 (en) * | 2014-06-09 | 2021-07-20 | Terumo Bct, Inc. | Lyophilization |
US20210396467A1 (en) * | 2018-09-27 | 2021-12-23 | Maat Pharma | Lyophilisation container |
US11377276B2 (en) * | 2016-08-05 | 2022-07-05 | Bachem Holding Ag | Drying container |
US20220340961A1 (en) * | 2021-04-27 | 2022-10-27 | Enplas Corporation | Freeze-dried structure and producing method thereof |
US11529587B2 (en) | 2019-05-03 | 2022-12-20 | Cellphire, Inc. | Materials and methods for producing blood products |
US11604026B2 (en) * | 2019-03-14 | 2023-03-14 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
US11634257B2 (en) * | 2017-10-09 | 2023-04-25 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
US11701388B2 (en) | 2019-08-16 | 2023-07-18 | Cellphire, Inc. | Thrombosomes as an antiplatelet agent reversal agent |
US11767511B2 (en) | 2018-11-30 | 2023-09-26 | Cellphire, Inc. | Platelets as delivery agents |
US11806431B2 (en) | 2014-09-19 | 2023-11-07 | Velico Medical, Inc. | Formulations and methods for contemporaneous stabilization of active proteins during spray drying and storage |
US11841189B1 (en) | 2022-09-15 | 2023-12-12 | Velico Medical, Inc. | Disposable for a spray drying system |
US11903971B2 (en) | 2020-02-04 | 2024-02-20 | Cellphire, Inc. | Treatment of von Willebrand disease |
US11965178B2 (en) | 2018-11-30 | 2024-04-23 | Cellphire, Inc. | Platelets loaded with anti-cancer agents |
US11975274B2 (en) | 2022-09-15 | 2024-05-07 | Velico Medical, Inc. | Blood plasma product |
US11994343B2 (en) | 2023-07-11 | 2024-05-28 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140083628A1 (en) | 2012-09-27 | 2014-03-27 | Velico Medical, Inc. | Spray drier assembly for automated spray drying |
CN112810954A (en) * | 2020-12-30 | 2021-05-18 | 上海东富龙医用包装材料有限公司 | Disposable sterile container applied to freeze-drying process |
CN113101213B (en) * | 2021-04-22 | 2022-09-16 | 上海乐纯生物技术有限公司 | Special liquid storage bag for cell therapy |
Citations (134)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1441570A (en) | 1920-08-12 | 1923-01-09 | Fitzgerald Frederic Will Vesey | Process for the preparation of commercial products from blood |
US1504225A (en) | 1921-05-19 | 1924-08-12 | Fitzgerald Frederic Will Vesey | Process for the preparation of commercial products from blood |
GB450146A (en) | 1934-01-31 | 1936-07-06 | Sharp & Dohme Inc | Biologically active substances and process of producing the same |
US2704075A (en) | 1952-03-10 | 1955-03-15 | Baxter Don Inc | Flexible plastic container |
GB748784A (en) | 1953-06-12 | 1956-05-09 | Edwards & Co London Ltd W | Improvements in or relating to vacuum freezing and/or vacuum freeze drying methods and apparatus |
US2767117A (en) | 1953-10-22 | 1956-10-16 | Crawley John Frederick | Poultry virus vaccine products and method of preparing the same |
GB814491A (en) | 1956-01-17 | 1959-06-03 | American Home Prod | Lipid mobiliser |
US3187750A (en) | 1963-01-15 | 1965-06-08 | Baxter Laboratories Inc | Multiple bag blood storage unit |
US3229813A (en) | 1959-05-08 | 1966-01-18 | Johnson & Johnson | Sterile package |
US3247957A (en) | 1964-08-17 | 1966-04-26 | Hospital Supply And Dev Compan | Sterile packaging and the like |
US3375824A (en) | 1965-07-08 | 1968-04-02 | Air Force Usa | Self-contained plasma administration pack |
US3466249A (en) | 1967-02-13 | 1969-09-09 | Baxter Laboratories Inc | Blood serum reference standard for multi-automated analytical procedures |
US3468471A (en) | 1965-06-24 | 1969-09-23 | Fritz Linder | Bacteriaproof plastic bag for articles to be sterilized |
GB1206033A (en) | 1967-01-24 | 1970-09-23 | Grace W R & Co | Improvements in or relating to methods of processing food |
US3537189A (en) | 1968-10-14 | 1970-11-03 | Virtis Co Inc | Removable tray and cover lift assembly |
US3571940A (en) | 1969-04-21 | 1971-03-23 | Cenco Medical Health Supply Co | Thermal cassette |
US3574950A (en) | 1969-06-12 | 1971-04-13 | Jospeh L Dantoni | Lyophilizing apparatus |
US3607858A (en) | 1970-03-31 | 1971-09-21 | American Cyanamid Co | Process for preparing lyophilized human blood proteins such as gamma globulin in the presence of a nonionic surfactant |
US3945523A (en) | 1973-06-25 | 1976-03-23 | Applied Bioscience | Freeze storage container system |
US3964865A (en) | 1975-01-30 | 1976-06-22 | Sigma Chemical Company | Lyophilized human hemoglobin standard for colorimetric determination of total hemoglobin |
US4001944A (en) | 1975-08-25 | 1977-01-11 | Parke, Davis & Company | Freeze-drying process |
DE2617742A1 (en) | 1974-12-31 | 1977-06-30 | Behringwerke Ag | Stabilisation of freeze-dried blood plasma - by storage in an atmos. contg. carbon dioxide |
US4035924A (en) | 1974-09-11 | 1977-07-19 | Societe D'assistance Technique Pour Produits Nestle S.A. | Freeze-drying of solid, liquid or paste-like products |
GB1486787A (en) | 1973-10-23 | 1977-09-21 | Behringwerke Ag | Process for stabilizing protein containing liquids |
US4056484A (en) | 1974-12-31 | 1977-11-01 | Behringwerke Aktiengesellschaft | Stable blood plasma, process for preparing it and its use as comparative plasma in coagulation tests |
US4109396A (en) | 1976-12-06 | 1978-08-29 | Fts Systems, Inc. | Method and apparatus for an improved shelf and tray assembly for a freeze dryer |
US4134943A (en) | 1975-12-16 | 1979-01-16 | Boehringer Mannheim Gmbh | Production of porous tablets |
US4218321A (en) | 1977-08-05 | 1980-08-19 | Agency Of Industrial Science & Technology | Device for removal of excess water from blood |
US4650678A (en) | 1982-02-04 | 1987-03-17 | Behringwerke Aktiengesellschaft | Readily dissolvable lyophilized fibrinogen formulation |
US4664913A (en) | 1982-05-24 | 1987-05-12 | Xoma Corporation | Method for treating plasma for transfusion |
JPS6336828A (en) | 1986-07-30 | 1988-02-17 | Showa Denko Kk | Production of dried particulate material and vacuum freeze dryer |
US4730460A (en) | 1987-02-09 | 1988-03-15 | Castleton, Inc. | Ultra - rapid plasma freezing with halocarbon heat transfer liquids |
EP0284249A1 (en) | 1987-03-13 | 1988-09-28 | Interferon Sciences, Inc. | Lyophilized lymphokine composition |
US4813210A (en) | 1985-09-27 | 1989-03-21 | Nissho Corporation | Radiation-sterilized, packaged medical device |
EP0335682A1 (en) | 1988-03-31 | 1989-10-04 | Hercules Incorporated | Water-permeable controlled atmosphere packaging device from cellophane and microporous film |
US4874690A (en) | 1988-08-26 | 1989-10-17 | Cryopharm Corporation | Lyophilization of red blood cells |
US4902287A (en) | 1987-09-24 | 1990-02-20 | Miles Inc. | Sterilizable system for blood storage |
US4904641A (en) | 1988-01-12 | 1990-02-27 | Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte | Method of inactivating reproducible filterable pathogens in blood plasma products |
US4973327A (en) | 1989-11-01 | 1990-11-27 | Cryopharm | Blood bag for lyophilization |
US5043261A (en) | 1989-04-10 | 1991-08-27 | Cryopharm Corporation | Lyophilized and reconstituted red blood cell and hemosome compositions |
US5045446A (en) | 1988-08-26 | 1991-09-03 | Cryopharm Corporation | Lyophilization of cells |
US5059036A (en) | 1990-04-27 | 1991-10-22 | Kapak Corporation | Vented pouch arrangement and method |
EP0343596B1 (en) | 1988-05-26 | 1992-03-04 | Roche Diagnostics GmbH | Container for freeze drying under sterile conditions |
US5114004A (en) | 1990-02-14 | 1992-05-19 | Material Engineering Technology Laboratory Inc. | Filled and sealed, self-contained mixing container |
US5171661A (en) | 1988-05-18 | 1992-12-15 | Cryopharm Corporation | Medium for lyophilization of erythrocytes |
US5178884A (en) | 1988-05-18 | 1993-01-12 | Cryopharm Corporation | Lyophilized and reconstituted red blood cell compositions |
US5213814A (en) | 1989-04-10 | 1993-05-25 | Cryopharm Corporation | Lyophilized and reconstituted blood platelet compositions |
US5257983A (en) | 1991-04-12 | 1993-11-02 | Cryopharm Corporation | Blood bag for lyophilization |
US5309649A (en) | 1988-05-26 | 1994-05-10 | Boehringer Mannheim Gmbh | Process and container for freeze drying under sterile conditions |
US5340592A (en) | 1988-05-18 | 1994-08-23 | Cobe Laboratories, Inc. | Lyophilization of erythrocytes |
WO1995027180A1 (en) | 1994-04-04 | 1995-10-12 | W.L. Gore & Associates, Inc. | Improved method for minimizing contamination of freeze-dried products |
US5514123A (en) | 1993-04-01 | 1996-05-07 | Abbott Laboratories | Sterile formed, filled and sealed flexible container |
US5551781A (en) | 1995-04-21 | 1996-09-03 | Wilkes; Kenneth R. | Sterilizable container and method of fabrication |
WO1996029556A1 (en) | 1995-03-18 | 1996-09-26 | The Wellcome Foundation Limited | Freeze-drying process and apparatus |
WO1996031748A1 (en) | 1995-04-07 | 1996-10-10 | W.L. Gore & Associates, Inc. | A freeze-drying bag and method for minimizing contamination of freeze-dried products |
US5656498A (en) | 1994-02-22 | 1997-08-12 | Nippon Telegraph And Telephone Corporation | Freeze-dried blood cells, stem cells and platelets, and manufacturing method for the same |
US5759774A (en) | 1988-05-18 | 1998-06-02 | Cobe Laboratories, Inc. | Method of detecting circulating antibody types using dried or lyophilized cells |
US5849473A (en) | 1991-02-15 | 1998-12-15 | Cobe Laboratories, Inc. | Method of lyophilization of mammalian sperm cells |
US5853388A (en) | 1997-08-21 | 1998-12-29 | Semel; David | Intravenous bag with separate compartment |
DE19729778A1 (en) | 1997-07-11 | 1999-01-21 | Blutspendedienst Der Drk Lande | Process for the preparation of virus-inactivated biological fluids |
US5946931A (en) | 1998-02-25 | 1999-09-07 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Evaporative cooling membrane device |
US6007529A (en) | 1996-04-10 | 1999-12-28 | Pharmacia & Upjohn Ab | Containers for parenteral fluids |
WO2000036353A1 (en) | 1998-12-12 | 2000-06-22 | University Of Strathclyde | Method for drying a material in a container having one or more pierced holes |
US6132454A (en) | 1996-05-03 | 2000-10-17 | Hotties Thermal Packs Limited | Heat pack |
US6148536A (en) | 1996-06-10 | 2000-11-21 | Nippon Telegraph And Telephone Corporation | Two-fluid nozzle and device employing the same nozzle for freezing and drying liquid containing biological substances |
US6199297B1 (en) | 1999-02-01 | 2001-03-13 | Integrated Biosystems, Inc. | Lyophilization apparatus and methods |
US6221575B1 (en) | 1997-02-07 | 2001-04-24 | Quadrant Holdings Cambridge Ltd. | Methods for producing dried storage-stable platelets and compositions obtained thereby |
US20020035354A1 (en) | 2000-06-21 | 2002-03-21 | The Procter & Gamble Company | Absorbent barrier structures having a high convective air flow rate and articles made therefrom |
US6381870B1 (en) | 2000-01-07 | 2002-05-07 | Milliken & Company | Bag for home dry cleaning process |
US6517526B1 (en) * | 2000-12-29 | 2003-02-11 | Yehuda Tamari | Container for lyophilizing biological products |
US20030065149A1 (en) | 2001-04-18 | 2003-04-03 | Northfield Laboratories | Stabilized hemoglobin solutions |
US6608237B1 (en) | 2000-08-03 | 2003-08-19 | Kimberly-Clark Worldwide, Inc. | High-strength, stabilized absorbent article |
US20040081588A1 (en) | 2002-10-23 | 2004-04-29 | Hammerstedt Roy H. | Integrated container for lyophilization, rehydration and processing of biological materials |
EP1087990B1 (en) | 1998-06-23 | 2004-09-22 | Shanbrom Technologies, LLC | Method and apparatus for the production of purified plasma proteins |
US6869901B2 (en) | 2001-02-20 | 2005-03-22 | Pactiv Corporation | Protective drainage wraps |
US6981337B2 (en) | 2002-01-30 | 2006-01-03 | Reckitt Benckiser (Uk) Limited | Device for absorbing water vapor |
WO2006000422A1 (en) | 2004-06-29 | 2006-01-05 | Baxter International Inc. | Method for the bulk production of a lyophilisate of a mafosfamide-lysine salt with high storage stability |
WO2006028648A2 (en) | 2004-08-13 | 2006-03-16 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Support system for flexible lyophilization containers |
US7048709B2 (en) | 2001-06-12 | 2006-05-23 | Macopharma | Bag provided with means for the temporary association of a filter |
US20060216687A1 (en) | 2002-12-24 | 2006-09-28 | Odilio Alves-Filho | Reconstitutable dried blood products |
US20060263759A1 (en) | 2003-03-06 | 2006-11-23 | Odilio Alves-Filho | Dried blood plasma product |
US7175614B2 (en) | 2002-10-17 | 2007-02-13 | Baxter International Inc. | Peelable seal |
US7179951B2 (en) | 2000-06-21 | 2007-02-20 | The Procter & Gamble Company | Absorbent barrier structures having a high convective air flow rate and articles made therefrom |
US7249880B2 (en) | 2003-10-14 | 2007-07-31 | Advanced Technology Materials, Inc. | Flexible mixing bag for mixing solids, liquids and gases |
WO2007104760A2 (en) | 2006-03-14 | 2007-09-20 | Johannes-Gutenberg-Universität Mainz | Plasma lyophilisate |
US7363726B2 (en) * | 2004-01-23 | 2008-04-29 | Zhaolin Wang | Powder formation by atmospheric spray-freeze drying |
EP1958618A1 (en) | 2007-02-15 | 2008-08-20 | Octapharma AG | Method for freeze-drying with optimum reconstitution of biopolymers |
US20080206293A1 (en) | 2004-02-25 | 2008-08-28 | Quick-Med Technologies, Inc. | Absorbent substrate with a non-leaching antimicrobial activity and a controlled-release bioactive agent. |
US20080234654A1 (en) * | 2007-03-19 | 2008-09-25 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US20080249499A1 (en) | 2006-06-22 | 2008-10-09 | Baxter International Inc. | Medicant delivery system |
US20080256822A1 (en) | 2007-04-19 | 2008-10-23 | Hiroko Suzuki | Container for freeze-drying |
US20090036862A1 (en) | 2007-08-01 | 2009-02-05 | Owens-Ilinois Healthcare Packaging Inc. | Multilayer plastic container and method of storing lyophilized products |
US20090107001A1 (en) | 2007-03-19 | 2009-04-30 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US20090113753A1 (en) | 2007-03-19 | 2009-05-07 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US20090223080A1 (en) | 2007-03-19 | 2009-09-10 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US7618406B2 (en) | 2007-01-22 | 2009-11-17 | Baxter International, Inc. | Break seal before access dual chamber bag |
US20090324929A1 (en) | 2008-06-25 | 2009-12-31 | Keiichi Yamakawa | Composite Membrane and Moisture Adjustment Module Using Same |
US20100049156A1 (en) | 2008-08-19 | 2010-02-25 | Drk-Blutspendedienst West Ggmbh | Non-collapsible and non-foldable container for lyophilization of a product |
US7931919B2 (en) | 2005-08-12 | 2011-04-26 | The United States Of America As Represented By The Secretary Of The Army | Method of producing glycine-stabilized, lyophilized plasma |
US20110114524A1 (en) | 2008-06-23 | 2011-05-19 | Bio-Products & Bio-Engineering Ag | Storage-stable, functionally intact fibrinogen |
US7966746B2 (en) | 2006-04-24 | 2011-06-28 | Medical Instill Technologies, LLC | Needle penetrable and laser resealable lyophilization method |
US20110183311A1 (en) | 2010-01-27 | 2011-07-28 | David Ho | Dry platelet preparations for use in diagnostics |
US8013022B2 (en) * | 2003-12-08 | 2011-09-06 | Deangelo Joseph | Stabilized products, process and devices for preparing same |
US8057872B2 (en) | 2008-08-26 | 2011-11-15 | E. I. Du Pont De Nemours And Company | Gas permeable membranes |
US20110282325A1 (en) | 2009-01-26 | 2011-11-17 | Ore-gon Biomedical Engineering Institute | Dehydrated plasma kit |
US8097403B2 (en) | 2006-12-14 | 2012-01-17 | Cellphire, Inc. | Freeze-dried platelets, method of making and method of use as a diagnostic agent |
US20120231485A1 (en) | 2011-03-08 | 2012-09-13 | Oenundarson Pall Torfi | Method for monitoring anticoagulant therapy |
US8372343B2 (en) | 2007-12-07 | 2013-02-12 | Sheldon Goldstein | Multiple coagulation test cartridge and method of using same |
EP1407780B1 (en) | 2001-07-10 | 2013-05-01 | The Chemo-Sero-Therapeutic Research Institute | Pharmaceutically stable hemostatic compositions |
WO2013062479A1 (en) | 2011-10-28 | 2013-05-02 | Glycorex Transplantation Ab | A method for extracorporeal elimination of one or more components from blood |
US8492081B2 (en) | 2003-05-16 | 2013-07-23 | The University Of North Carolina At Chapel Hill | Aldehyde-fixed, dried platelets with covalently attached exogenous active agent and method of making thereof |
US8491178B2 (en) | 2007-06-21 | 2013-07-23 | Gen-Probe Incorporated | Instruments and methods for mixing the contents of a detection chamber |
US8516714B2 (en) | 2008-01-21 | 2013-08-27 | Intervet International B.V. | Method for lyophilising particles having a pharmaceutical compound contained therein and a pharmaceutical pack containing such particles |
US20130326899A1 (en) | 2011-11-30 | 2013-12-12 | Shunichi Yagi | Freeze-drying method and apparatus for the same |
JP2014028661A (en) | 2007-04-23 | 2014-02-13 | Gore Enterprise Holdings Inc | Patterned porous venting materials |
WO2014033228A1 (en) | 2012-08-31 | 2014-03-06 | Flexiways Sprl | Flexible container for transporting products such as biocides |
EP2729932A1 (en) | 2011-07-07 | 2014-05-14 | Drexel University | Multi-touch piano keyboard |
US20140178513A1 (en) * | 2012-12-23 | 2014-06-26 | Robert Richard Matthews | Non ionic/electrolyte, liquid/gaseous, mechanically refined/nanoparticle dispersion Building Materials/High Wear-Heat Resistant Part Brushes, Windings, Battery Cells, Brake Pads, Die Cast Molding, Refrigeration, Polarized/Integrated Optical, Spectrometric Processors, Central Processor Unit Processors, Electronic Storage Media, Analogous Series/Parallel Circuit Generators/Transceivers, Particulate Matter PM Carbonaceous-Polyamide, Crystalline Silica, and Cellulosic Filament Extraction/Miners Suit |
US20140212895A1 (en) | 2013-01-25 | 2014-07-31 | Xcell Biosciences, Inc. | Cancer Analysis System |
US20140259724A1 (en) | 2013-03-13 | 2014-09-18 | Hemcon Medical Technologies, Inc. | Low Aspect Ratio Staged Closure Devices, Systems, and Methods for Freeze-Drying, Storing, Reconstituting, and Administering Lyophilized Plasma |
US20140287643A1 (en) | 2011-11-01 | 2014-09-25 | W. L. Gore & Associates, Co., Ltd. | Laminated cloth |
US20140360891A1 (en) | 2013-03-12 | 2014-12-11 | Bret E. Kline | System and method for using adsorbent/absorbent in loading, storing, delivering, and retrieving gases, fluids, and liquids |
US20150158652A1 (en) * | 2013-12-05 | 2015-06-11 | Vascular Solutions, Inc. | System and method for freeze-drying and packaging |
US9161527B2 (en) | 2007-12-21 | 2015-10-20 | Sartorius Stedim North America Inc. | Systems and methods for freezing, storing and thawing biopharmaceutical materials |
US20150354894A1 (en) * | 2014-06-09 | 2015-12-10 | Terumo Bct, Inc. | Lyophilization |
US20160084572A1 (en) | 2014-09-19 | 2016-03-24 | Velico Medical, Inc. | Process control methods for obtaining and maintaining a desired moisture content of spray dried plasma |
US9469835B2 (en) * | 2004-06-02 | 2016-10-18 | Victor Bronshtein | Preservation by vaporization |
US20160375184A1 (en) | 2009-12-22 | 2016-12-29 | Smith & Nephew, Inc. | Apparatuses and methods for negative pressure wound therapy |
US20170203871A1 (en) | 2016-01-18 | 2017-07-20 | Vascular Solutions, Inc. | System and method for freeze-drying and packaging |
US20170259186A1 (en) | 2010-10-29 | 2017-09-14 | Velico Medical, Inc. | Spray drier assembly for automated spray drying |
US9863701B2 (en) * | 2013-12-19 | 2018-01-09 | Aerosol Therapeutics, LLC | Compositions and methods for atmospheric spray freeze drying |
US20190106254A1 (en) * | 2017-10-09 | 2019-04-11 | Terumo Bct Biotechnologies, Llc | Lyophilization Container And Method Of Using Same |
US20190142694A1 (en) | 2017-05-31 | 2019-05-16 | Adienne Pharma & Biotech Sa | Multi Chamber Flexible Bag and Methods of Using Same |
US10492507B2 (en) * | 2017-05-11 | 2019-12-03 | Cornell University | Process for improving shelf-life of fresh cut vegetables and food products produced thereby |
Family Cites Families (596)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA843883A (en) | 1970-06-09 | Sun Oil Company | Azeotropic freeze-drying process | |
DE109659C (en) | ||||
CA780792A (en) | 1968-03-19 | Warner-Lambert Pharmaceutical Company | Lyophilized composition | |
CA835939A (en) | 1970-03-03 | N. V. Organon | Process for the preparation of erythrocytes suitable for immunochemical determinations and the manufacture of dosage unit forms therefrom | |
CA787838A (en) | 1968-06-18 | Fox Charles | Diagnostic aid | |
CA745958A (en) | 1966-11-08 | J. Fulthorpe Arthur | Pregnancy test | |
US136036A (en) | 1873-02-18 | Improvement in preparing blood for fertilizers | ||
DE112775C (en) | 1898-01-19 | 1900-07-30 | ||
GB353286A (en) | 1929-08-19 | 1931-07-23 | Adolphe Schulz | Improvements in or relating to the preparation and composition of food for fish |
US1956784A (en) | 1932-02-24 | 1934-05-01 | Albert G Mccaleb | Condimentation and coloration of foodstuffs |
GB425567A (en) | 1934-03-05 | 1935-03-18 | Hugh Earl Allen | Method and material for colouration and condimentation of food stuffs |
FR817535A (en) | 1936-03-05 | 1937-09-04 | Rohm & Haas Ag | Process for suppressing the harmful effect of copper compounds on enzymes used in the textile industry to break down starch |
GB620573A (en) | 1944-10-18 | 1949-03-28 | Distillation Products Inc | Improvements in vacuum dehydration |
US2619425A (en) | 1951-04-03 | 1952-11-25 | Levin Ezra | Drying and defatting tissue |
US2659986A (en) | 1951-12-12 | 1953-11-24 | Cutter Lab | Method of drying human serum albumin and other heat sensitive biologically active proteins |
GB731104A (en) | 1952-02-27 | 1955-06-01 | Ortho Pharma Corp | Improvement in preparation of blood fraction for use in rh testing procedure |
GB770075A (en) | 1954-03-15 | 1957-03-13 | Cutter Lab | Improvements in or relating to preparation of a fibrinogen product and stable solutions thereof |
GB807781A (en) | 1954-05-27 | 1959-01-21 | Ortho Pharma Corp | Plasma fraction and standard plasma preparation and method of preparing same |
US2912359A (en) | 1955-05-04 | 1959-11-10 | Developments Inc | Wound healing agent obtained from blood and method of preparation |
IT568716A (en) | 1956-02-03 | |||
US3057781A (en) | 1956-02-23 | 1962-10-09 | U S Pharmaceutical Inc | Stabilization of plasma with invert sugar |
GB853288A (en) | 1956-07-17 | 1960-11-02 | Paul Niehans | Process for the production of materials applicable for diagnostic and therapeutic purposes |
NL123584C (en) | 1958-05-16 | |||
GB859609A (en) | 1958-06-27 | 1961-01-25 | Armour & Co | Improvements in or relating to lyophilized protein hydrolysates |
US3024167A (en) | 1959-02-06 | 1962-03-06 | Armour & Company Of Delaware | Lyophilized protein hydrolysate suitable for parenteral administration |
US3008879A (en) | 1960-03-18 | 1961-11-14 | Miles Lab | Diagnostic composition for the quantitative determination of glucose |
US3092465A (en) | 1960-03-25 | 1963-06-04 | Miles Lab | Diagnostic test device for blood sugar |
US3123443A (en) | 1960-04-18 | 1964-03-03 | Composition for diagnosing glucose | |
US3236732A (en) | 1962-01-22 | 1966-02-22 | Edward R Arquilla | Pregnancy test method and immunological indicator therefor |
GB906860A (en) | 1961-03-30 | 1962-09-26 | Kenneth William Ernest Denson | Improvements relating to blood coagulation test reagents |
GB941019A (en) | 1961-04-27 | 1963-11-06 | Crookes Lab Ltd | Improvements in and relating to the stability of anti-haemophilic globulin (factor viii) |
NL105810C (en) | 1961-12-15 | |||
NL293434A (en) | 1962-02-05 | |||
GB1003748A (en) | 1962-11-13 | 1965-09-08 | Warner Lambert Pharmaceutical | Diagnostic compositions for the determination of blood coagulant factor levels |
NL134608C (en) | 1963-06-17 | |||
US3223593A (en) | 1963-08-14 | 1965-12-14 | Melpar Inc | Method of preparing immobilized serum cholinesterase and product thereof |
US3260648A (en) | 1963-08-16 | 1966-07-12 | Warner Lambert Pharmaceutical | Diagnostic aid |
US3292342A (en) | 1964-01-16 | 1966-12-20 | Copiague Res And Dev Company | Device for vacuum sealing |
US3294523A (en) | 1964-01-29 | 1966-12-27 | Robert P Morningstar | Vegetation growth promoter utilising blood as a major component |
US3395210A (en) | 1964-02-07 | 1968-07-30 | Warner Lambert Pharmaceutical | Lyophilized diagnostic reagent for the determination of blood coagulation factors |
US3228841A (en) | 1965-06-10 | 1966-01-11 | Warner Lambert Pharmaceutical | Diagnostic reagent composition for determining blood coagulation factors and method of use |
NL126573C (en) | 1965-08-02 | |||
NL126572C (en) | 1966-03-24 | |||
FR1484727A (en) | 1966-04-19 | 1967-06-16 | Immunological reagent and its method of obtaining | |
US3423290A (en) | 1966-08-03 | 1969-01-21 | Nasa | Lyophilized reaction mixtures |
US3519572A (en) | 1966-10-03 | 1970-07-07 | Pfizer & Co C | Blood control |
US3490437A (en) | 1966-10-17 | 1970-01-20 | Thomas T Bakondy | Embryonic organ cells in a state of preservation and methods for preserving the same |
NL130516C (en) | 1966-11-08 | |||
US3627878A (en) | 1967-11-06 | 1971-12-14 | Wilson Pharm & Chem Corp | Herbivore repellent and method |
GB1244344A (en) | 1967-11-13 | 1971-08-25 | Abbott Lab | Hemagglutination testing procedure employing stabilized and potentiated erythrocytes and a method for their preparation |
CH516935A (en) | 1968-02-12 | 1971-12-31 | Ministerstwo Zdrowia I Opieki | Process for the production of serums used in serological diagnosis |
US3533934A (en) | 1968-05-24 | 1970-10-13 | Mearl Corp | Method for dehydrating nacreous pigment platelets |
US3556760A (en) | 1968-06-28 | 1971-01-19 | Virtis Co Inc | Apparatus for heat sealing evacuated glass ampules |
CA920947A (en) | 1968-10-02 | 1973-02-13 | Y. C. Hew Howard | Prothrombin complex |
US3717708A (en) | 1968-10-24 | 1973-02-20 | Cutter Lab | Blood coagulation complex |
US3597321A (en) | 1969-04-17 | 1971-08-03 | Warner Lambert Pharmaceutical | Diagnostic compostion for the differentiation of staphylococci |
US3674860A (en) | 1969-07-14 | 1972-07-04 | Diamond Lab Inc | Anaplasmosis vaccines |
US3629142A (en) | 1969-12-08 | 1971-12-21 | Edward P Marbach | Reference standard blood serum for the calibration of automatic blood serum analyzing apparatus |
US3573063A (en) | 1969-12-31 | 1971-03-30 | Beverly E Williams | Processes for improving the flavor,tenderness,juiciness and appearance of meats using natural animal products |
FR2088139B1 (en) | 1970-05-22 | 1973-06-08 | Philips France | |
US3728226A (en) | 1970-06-01 | 1973-04-17 | Baxter Laboratories Inc | Blood serum analytical control standard |
US3932943A (en) | 1970-08-14 | 1976-01-20 | E. I. Du Pont De Nemours And Company | Method of preparation of lyophilized biological products |
US3730843A (en) | 1970-12-14 | 1973-05-01 | Pfizer | Mass screening test for serum trypsin inhibitors |
US4049673A (en) | 1971-06-08 | 1977-09-20 | Israel Herbert Scheinberg | Preparation of ferrous hemoglobin and enzymatic digestion products thereof active for absorption of carbon monoxide |
US3799740A (en) | 1971-07-12 | 1974-03-26 | Mallinckrodt Chemical Works | Clinical competitive-binding test methods |
FR2160285A1 (en) | 1971-11-17 | 1973-06-29 | Metzinger Albert | Embryonic serum-based compsn - used as a skin tonic |
US3753925A (en) | 1972-03-24 | 1973-08-21 | Baxter Laboratories Inc | Cerebrospinal fluid control standard |
FR2187909A1 (en) | 1972-06-08 | 1974-01-18 | Merieux Inst | Stable antigens - by freeze-drying antigen bonded to red blood cells |
US3831293A (en) | 1972-09-15 | 1974-08-27 | Baker Perkins Inc | Stacked tray processing and freezing system |
DE2349186C2 (en) | 1972-11-16 | 1982-11-11 | Solco Basel AG, Birsfelden | Medicines to improve cell respiration, heart muscle performance and brain function |
US3954663A (en) | 1972-12-18 | 1976-05-04 | Teikoku Horinine Mfg. Co. Ltd. | Process for the preparation of Limulina lysate |
SU461680A1 (en) | 1973-02-15 | 1976-07-05 | The method of obtaining substances with coronary expanding action | |
DE2310964A1 (en) | 1973-03-02 | 1974-09-05 | Schering Ag | ANTIGEN OR ANTIGEN PROTEIN CONJUGATE COATED ERYTHROCYTE PREPARATION |
FR2224118A1 (en) | 1973-04-05 | 1974-10-31 | Villequez Ernest | Serological detection of cancer using freeze-dried antigen - prepd. from blood of cancerous subjects |
DE2420415A1 (en) | 1973-04-27 | 1974-11-14 | Res Foundation Of Children S H | A MITOGENIC BLOOD FRACTION AND METHOD OF PRODUCING THE SAME |
US3859047A (en) | 1973-05-29 | 1975-01-07 | Hoffmann La Roche | Standard for serum cholesterol determination |
DE2430447A1 (en) | 1973-06-25 | 1975-01-23 | Applied Bioscience | FREEZER AND STORAGE CONTAINERS |
US3973002A (en) | 1974-04-12 | 1976-08-03 | E. R. Squibb & Sons, Inc. | Antihemophilic factor |
US3922145A (en) | 1974-05-28 | 1975-11-25 | Warner Lambert Co | Hypothyroid serum control |
US4080265A (en) | 1974-08-02 | 1978-03-21 | Antonik Alan S | Method for the determination of creative phosphokinase enzyme |
GB1480092A (en) | 1974-08-14 | 1977-07-20 | Warner Lambert Co | Diagnostic agent |
US3993585A (en) | 1975-01-27 | 1976-11-23 | American Cyanamid Company | Elevated human lipids control |
US4002739A (en) | 1975-02-18 | 1977-01-11 | Warner-Lambert Company | Soluble collagen |
GB1524712A (en) | 1975-03-18 | 1978-09-13 | Friesland Condensfab | Colouring of protein fibres |
GB1536725A (en) | 1975-04-21 | 1978-12-20 | Armour Pharma | Preparation of a blood protein fraction |
US4045176A (en) | 1975-06-13 | 1977-08-30 | Proksch Gary J | Preparation of optically clear serum |
US4188318A (en) | 1975-06-16 | 1980-02-12 | Edward Shanbrom | Simplified method for preparation of high yield, high purity Factor VIII concentrate |
NL7608763A (en) | 1975-08-13 | 1977-02-15 | Hoechst Ag | PROCESS FOR PREPARING TECHNETIUM SUITABLE TIN CONTAINING HUMAN SERUM ALBUMIN PARTICLES. |
DE2537618B2 (en) | 1975-08-23 | 1980-05-08 | Fa. Carl Freudenberg, 6940 Weinheim | Food additive |
DE2546166A1 (en) | 1975-10-15 | 1977-04-28 | Behringwerke Ag | TANNED THROMBOCYTE |
DE2551208C3 (en) | 1975-11-14 | 1981-05-27 | Behringwerke Ag, 3550 Marburg | Process for the production of a stable erythrocyte preparation |
US4089944A (en) | 1975-12-22 | 1978-05-16 | Baxter Travenol Laboratories, Inc. | Rapidly solubilized AHF composition and process for preparing same |
JPS5912991B2 (en) | 1976-02-02 | 1984-03-27 | 武田薬品工業株式会社 | Dilution solution for rubella HI antibody measurement |
SU548275A1 (en) | 1976-03-31 | 1977-02-28 | Центральный Ордена Ленина Научно-Исследовательский Институт Гематологии И Переливания Крови | The method of obtaining hyperimmune anti-purulent antitoxic human plasma |
DE2723070C2 (en) | 1976-05-24 | 1986-03-06 | Walter Philadelphia Pa. Brummund jun. | Reference preparation for determining a halide or carbonate concentration in chemical analyzes |
US4141856A (en) | 1976-05-24 | 1979-02-27 | Dorwart Jr William V | Reference material for establishing anion concentrations in analytical chemistry tests |
DE2624373C2 (en) | 1976-05-31 | 1983-02-03 | Arnold Dr. 8782 Karlstadt Seufert | Process for the production of sterile filtered cryoprecipitate with an enrichment of factor VIII |
JPS52156921A (en) | 1976-06-21 | 1977-12-27 | Uerumaa Japan Yuugen | Antibody detecting agent |
SU654238A1 (en) | 1976-08-13 | 1979-03-30 | Всесоюзный Научно-Исследовательский Институт Холодильной Промышленности | Method and device for concentrating liquid products |
US4284725A (en) | 1976-08-13 | 1981-08-18 | Dynasciences Corporation | Virus titration and identification system |
CA1054052A (en) | 1976-08-14 | 1979-05-08 | Edward Shanbrom | Simplified method for preparation of high yield, high purity factor viii concentrate |
FR2363577A1 (en) | 1976-09-03 | 1978-03-31 | Recherches Hematologiques | Concn. and purification of plasma antihaemophilic factor - by cryoprecipitation , extn. into water, cooling to ppte. fibrinogen and lyophilising |
US4323478A (en) | 1977-01-18 | 1982-04-06 | Baxter Travenol Laboratories, Inc. | Novel particulate compositions |
JPS5391117A (en) | 1977-01-20 | 1978-08-10 | Honma Kenkyusho | Production of complement for complement binding reaction by freeze drying |
US4287087A (en) | 1977-02-25 | 1981-09-01 | Research Triangle Institute | Fixed-dried blood platelets |
GB1530748A (en) | 1977-05-03 | 1978-11-01 | Worthington Biochem Corp | Limulus lysate turbidity test for pyrogens |
SU686732A1 (en) | 1977-05-05 | 1979-09-25 | Владивостокский государственный медицинский институт | Arrangement for keeping and showing of placards |
US4127502A (en) | 1977-06-10 | 1978-11-28 | Eastman Kodak Company | Stabilizers for reconstituted, lyophilized samples |
FR2399024A1 (en) | 1977-07-25 | 1979-02-23 | Biotrol Sa Lab | METHOD AND DEVICE FOR ANALYZING AND DETERMINING CONSTITUENTS OF SOLID OR LIQUID MEDIA |
JPS5426961A (en) | 1977-08-03 | 1979-02-28 | Toho Rayon Kk | Method of dehydrating sludge |
US4189400A (en) | 1977-08-17 | 1980-02-19 | Bonderman Dean P | Compound useful in cholesterol assay procedures |
US4155186A (en) | 1978-03-16 | 1979-05-22 | Robinson Robert T | Anti-shark weapon |
US4337240A (en) | 1978-04-20 | 1982-06-29 | New England Nuclear Corporation | Denatured albumin complexes for radioscintigraphic imaging and evaluation of reticuloendothelial systems |
SU700129A1 (en) | 1978-06-14 | 1979-11-30 | Киевский Научно-Исследовательский Институт Гематологии И Переливания Крови | Method of obtaining hemostatic diseases |
US4324685A (en) | 1978-07-17 | 1982-04-13 | Beckman Instruments, Inc. | Blood serum reference standard |
US4202665A (en) | 1978-11-06 | 1980-05-13 | Albert Einstein College Of Medicine Of Yeshiva University A Division Of Yeshiva University | Detection of hepatitis B surface antigen |
JPS5571452A (en) | 1978-11-24 | 1980-05-29 | Kiko Kaihatsu:Kk | Device for boil-treatment of animal blood |
CA1126653A (en) | 1978-12-22 | 1982-06-29 | Jan H. Luijerink | Process of preparing blood cell protein and heme from hemoglobin |
DE2900621C3 (en) | 1979-01-09 | 1982-01-21 | Bison-Werke Bähre & Greten GmbH & Co KG, 3257 Springe | Method of making an adhesive from animal blood |
SU786954A1 (en) | 1979-02-12 | 1980-12-15 | Ростовский государственный медицинский институт | Method of preserving vessels |
AT361135B (en) | 1979-06-27 | 1981-02-25 | Immuno Ag | METHOD FOR PRESERVING THE ELECTRO-PHORETIC PROPERTIES OF LIPOPROTEINS |
FR2475737A1 (en) | 1980-02-07 | 1981-08-14 | Pasteur Institut | Preservation of red blood corpuscles - suitable for use as haemagglutination standards, by aldehyde treatment and lyophilisation |
JPS56127308A (en) | 1980-03-11 | 1981-10-06 | Green Cross Corp:The | Blood-coagulation factor 8 pharmaceutical |
JPS56127307A (en) | 1980-03-11 | 1981-10-06 | Green Cross Corp:The | Blood-coagulation factor 8 pharmaceutical for oral administration |
JPS56160991A (en) | 1980-05-15 | 1981-12-11 | Atsuyuki Kato | Stabilized dihydrofolate reductase |
JPS5772911A (en) | 1980-10-24 | 1982-05-07 | Green Cross Corp:The | Peparation of preserved perfusate for transplanted organ |
JPS57122796A (en) | 1980-12-09 | 1982-07-30 | American Hospital Supply Corp | Stabilized creatinekinase control |
DE3107060A1 (en) | 1981-02-25 | 1982-09-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | CONTROL OR CALIBRATION SERUM AND METHOD FOR THE PRODUCTION THEREOF |
JPS57142561A (en) | 1981-02-28 | 1982-09-03 | Masaaki Makino | Blood coagulation promoting agent for serum separation and its manufacture |
JPS57159561A (en) | 1981-03-24 | 1982-10-01 | Sekisui Chem Co Ltd | Serum or blood plasma-separator |
US4495278A (en) | 1981-04-27 | 1985-01-22 | Baxter Travenol Laboratories, Inc. | Process for making novel blood clotting enzyme compositions |
US4442655A (en) | 1981-06-25 | 1984-04-17 | Serapharm Michael Stroetmann | Fibrinogen-containing dry preparation, manufacture and use thereof |
US4465774A (en) | 1981-07-16 | 1984-08-14 | Sherwood Medical Company | Standard or control material for glysocylated or total hemoglobin determination |
US4456590B2 (en) | 1981-11-02 | 1989-05-30 | Heat treatment of lyphilized blood clotting factor viii concentrate | |
JPS58138441A (en) | 1982-02-15 | 1983-08-17 | テルモ株式会社 | Bloood sampler |
EP0105923A4 (en) | 1982-04-20 | 1984-09-06 | Cooper Lab | Method and composition for elevated lipid quality control materials. |
JPS58131566A (en) | 1982-04-28 | 1983-08-05 | Green Cross Corp:The | Lyophilized matter of red blood cell |
US4581231A (en) | 1982-06-10 | 1986-04-08 | The United States Of America As Represented By The Secretary Of Health And Human Services | Inactivation of viruses containing essential lipids |
IT8222194V0 (en) | 1982-06-18 | 1982-06-18 | Edwards Alto Vuoto Spa | DEVICE FOR LOADING THE PRODUCT-HOLDER PLATES OF A LYOPHILIZATION CHAMBER THROUGH THE USE OF CONSTITUTED CONSTANT HEIGHT CONTAINERS. |
US4614795A (en) | 1982-08-05 | 1986-09-30 | University Of Rochester | Deglycosylated Human Factor VIII:C |
US4722790A (en) | 1982-09-13 | 1988-02-02 | Cawley Leo P | On-line plasma modification means |
JPS5988042A (en) | 1982-11-11 | 1984-05-21 | Asahi Chem Ind Co Ltd | Purified blood plasma and artificial milk for animal containing the same |
US4543335A (en) | 1982-12-20 | 1985-09-24 | Miles Laboratories, Inc. | Device and method for the quantitative determination of heparin in mammalian blood plasma |
DE3247150A1 (en) | 1982-12-21 | 1984-06-28 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | CLOTHING ACTIVE PLASMA PROTEIN REDUCTION, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR TREATING DISORDERS OF THE HAEMOSTASE SYSTEM |
JPS59136657A (en) | 1983-01-26 | 1984-08-06 | Green Cross Corp:The | Reagent for measuring eighth factor of blood clotting |
JPS59181224A (en) | 1983-03-29 | 1984-10-15 | Sumitomo Chem Co Ltd | Production of stabilized interferon preparation |
CA1236396A (en) | 1983-04-01 | 1988-05-10 | Ryozo Numazawa | Endotoxin-detecting device |
JPS59192961A (en) | 1983-04-15 | 1984-11-01 | Green Cross Corp:The | Reagent for measuring xiii-th factor of blood coagulation |
ATE31023T1 (en) | 1983-04-28 | 1987-12-15 | Armour Pharma | PHARMACEUTICAL PREPARATION CONTAINING PURIFIED FIBRINONECTIN. |
DE3473407D1 (en) | 1983-05-02 | 1988-09-22 | Immuno Ag | Method of inactivating pathogens |
JPS59212768A (en) | 1983-05-18 | 1984-12-01 | Green Cross Corp:The | Reagent for measuring protein associated with basement membrane bmap originating in human placenta |
JPS59218960A (en) | 1983-05-27 | 1984-12-10 | Naraken | X-th factor deficit plasma |
JPS6024163A (en) | 1983-07-21 | 1985-02-06 | Create:Kk | Preparation of powdered blood |
DD219378A1 (en) | 1983-10-17 | 1985-03-06 | Adw Ddr | METHOD FOR PRODUCING COMBINED PROTEIN SHAPES |
JPH0228098B2 (en) | 1984-02-13 | 1990-06-21 | Mitsubishi Rayon Co | ENDOTOKISHINKENSHUTSUHO |
WO1985004348A1 (en) | 1984-03-26 | 1985-10-10 | International Health Services | Specimen bag and injection assembly |
EP0158487B1 (en) | 1984-04-09 | 1991-08-28 | Takeda Chemical Industries, Ltd. | Stable composition of interleukin-2 |
US4717654A (en) | 1984-06-19 | 1988-01-05 | Akzo N.V. | Process for solid phase platelet antibody assay |
JPS6140752A (en) | 1984-07-31 | 1986-02-27 | Tatsumi Chikura | Production of feed, etc., from blood, etc., of animal, or fish and shellfish |
JPS6153567A (en) | 1984-08-24 | 1986-03-17 | Nippon Hebizoku Gakujiyutsu Kenkyusho | Manufacturing of blood coagulation promotor for separation of serum from hime habu poison |
SU1344354A1 (en) | 1984-09-17 | 1987-10-15 | 1-Й Московский Медицинский Институт Им.И.М.Сеченова | Method of treatment of cornea burns |
CA1260389A (en) | 1984-10-10 | 1989-09-26 | Jay A. Levy | Human plasma, plasma fractions, and compositions thereof substantially free of infectious viruses, bacteria and retroviruses |
HU192513B (en) | 1984-11-23 | 1987-06-29 | Human Oltoanyagtermelo | Quick diagnostic substance for determining blood group |
JPS61128974A (en) | 1984-11-27 | 1986-06-17 | 株式会社アドバンス | Artificial base membrane and its production |
JPS61155332A (en) | 1984-12-28 | 1986-07-15 | Chemo Sero Therapeut Res Inst | Method of treating blood coagulation factor viii |
GB8505882D0 (en) | 1985-03-07 | 1985-04-11 | Central Blood Lab Authority | Purification of blood coagulation factor viii |
JPS61225652A (en) | 1985-03-29 | 1986-10-07 | Mitsubishi Rayon Co Ltd | Manufacture of easy-to-dissolve blood anticoagulant |
NO852655L (en) | 1985-06-05 | 1986-12-08 | Bio Data Corp | PROCEDURE FOR PREPARING COGULATION REAGENTS FOR BLOOD PLASMA IN MICROCENTRANTED TABLET FORM. |
JPS61282054A (en) | 1985-06-10 | 1986-12-12 | Houetsu:Kk | Health-promoting agent and production thereof |
DE3675588D1 (en) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | HAEMOGLOBIN TIED TO A POLY (ALKENYLENE OXIDE). |
JPH0635391B2 (en) | 1985-07-05 | 1994-05-11 | 株式会社ミドリ十字 | Heat treatment method for human blood coagulation factor IX-containing preparation |
US4780314A (en) | 1985-10-30 | 1988-10-25 | Brigham And Women's Hospital | Isolation and purification of a digitalis-like factor |
IT1186787B (en) | 1985-11-06 | 1987-12-16 | Mediolanum Farmaceutici Srl | IRON-DERIVATIVES OF GLOBIN AND ACETYLGLOBIN EQUIPPED WITH HIGH BIOAVAILABILITY, PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS |
JPH06104626B2 (en) | 1985-12-10 | 1994-12-21 | 修三 中園 | How to collect powdered blood components |
WO1987005220A1 (en) | 1986-03-10 | 1987-09-11 | Rubinstein Alan I | A method for treating gammaglobulin |
US4806343A (en) | 1986-03-13 | 1989-02-21 | University Of Southwestern Louisiana | Cryogenic protectant for proteins |
US4731330A (en) | 1986-07-01 | 1988-03-15 | Biotrack, Inc. | Whole blood control sample |
FR2600998B1 (en) | 1986-07-02 | 1992-08-14 | Cazalens Georges | ADJUVANT COMPOSITION OF HYDRAULIC BINDER OR GRINDING BASED ON BLOOD PROTEINS WITH AN ANTI-FOAM PRODUCT, USE AND HYDRAULIC BINDER OBTAINED |
JPH07114635B2 (en) | 1986-08-29 | 1995-12-13 | 鶴吉 横川 | Blood meal manufacturing method and device |
ATE180496T1 (en) | 1987-01-08 | 1999-06-15 | Asahi Chemical Ind | PEPTIDE TO ACCELERATE THE ACTION OF PROTEIN-C WITH THROMBIN |
US5118795A (en) | 1987-05-15 | 1992-06-02 | University Of Southern California | Sequential heat treatment of blood-clotting factor products |
DK398987D0 (en) | 1987-07-30 | 1987-07-30 | Wismer Pedersen Joergen | METHOD OF PRODUCING BLOOD PROTEIN |
US5260420A (en) | 1987-07-30 | 1993-11-09 | Centre Regional De Transfusion Sanguine De Lille | Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof |
CA1329760C (en) | 1987-10-29 | 1994-05-24 | Ted C. K. Lee | Plasma and recombinant protein formulations in high ionic strength media |
US4877608A (en) | 1987-11-09 | 1989-10-31 | Rorer Pharmaceutical Corporation | Pharmaceutical plasma protein formulations in low ionic strength media |
SU1592717A1 (en) | 1987-12-15 | 1990-09-15 | Kirov Nii Gematologii Pereliva | Method of producing donor standard plasma |
IL84911A (en) | 1987-12-22 | 1993-04-04 | Yissum Res Dev Co | Processes for the preparation of collagen products, and pharmaceutical compositions containing the same |
JPH01247060A (en) | 1988-03-28 | 1989-10-02 | Kagoshima Giyofun Kogyo Kk | Production of powdered blood from blood of animal, fishes or the like |
US4850353A (en) | 1988-08-08 | 1989-07-25 | Everest Medical Corporation | Silicon nitride electrosurgical blade |
JPH0650999B2 (en) | 1988-09-12 | 1994-07-06 | 日本商事株式会社 | Blood coagulation factor stabilization method |
US5059518A (en) | 1988-10-20 | 1991-10-22 | Coulter Corporation | Stabilized lyophilized mammalian cells and method of making same |
US4877741A (en) | 1988-10-24 | 1989-10-31 | The United States Of America As Represented By The Secretary Of The Air Force | Treatment of human plasma with brown recluse spider toxin to emulate a lupus anticoagulant |
SU1716443A1 (en) | 1988-12-06 | 1992-02-28 | Казахский научно-исследовательский институт глазных болезней | Method for glaucoma diagnosis |
EP0485377B1 (en) | 1988-12-12 | 1999-05-06 | Csl Limited | Solid phase immuno-assay with labelled conjugate |
JPH02221859A (en) | 1989-02-21 | 1990-09-04 | J M L:Kk | Hemoglobin stabilizer |
JPH0211239A (en) | 1989-02-27 | 1990-01-16 | Matsutani Seisakusho:Kk | Method for forming hole for eyeless sutural needle |
JP2657092B2 (en) | 1989-03-27 | 1997-09-24 | ボンタン レイモン | Apparatus for storing freezeable cosmetic substances and cosmetics made from fetuses |
ES2070942T3 (en) | 1989-04-07 | 1995-06-16 | Abbott Lab | METHOD AND DEVICE FOR THE SEPARATION OF PLASMA OR WHOLE BLOOD SERUM. |
DE9001612U1 (en) | 1989-04-07 | 1990-04-19 | Leybold Ag, 6450 Hanau, De | |
DE3914869C1 (en) | 1989-05-05 | 1990-08-09 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
SU1678371A1 (en) | 1989-06-21 | 1991-09-23 | Иркутский научно-исследовательский противочумный институт Сибири и Дальнего Востока | Rabbit immune diagnostic sera dosing method |
GB8923998D0 (en) | 1989-10-25 | 1989-12-13 | Nestle Sa | Food additives |
KR910005622B1 (en) | 1989-11-22 | 1991-08-01 | 한국 식품개발 연구원 | Product of food usable blood of stock |
US5063178A (en) | 1990-03-19 | 1991-11-05 | Medex, Inc. | Freeze-dried blood gas sensor |
DE69133198T2 (en) | 1990-04-16 | 2003-07-24 | Baxter Int | METHOD FOR INHALITATING VIRAL AND BACTERIAL BLOOD IMPURITIES |
RU2028130C1 (en) | 1990-04-17 | 1995-02-09 | Чередниченко Лев Павлович | Method for treating ulcer of cornea |
US5547873A (en) | 1994-02-22 | 1996-08-20 | Genzyme Corporation | Compositions for stabilizing proteins for long term dry storage and methods of making and using the compositions |
US5420250A (en) | 1990-08-06 | 1995-05-30 | Fibrin Corporation | Phase transfer process for producing native plasma protein concentrates |
AT402367B (en) | 1990-10-11 | 1997-04-25 | Immuno Ag | PHARMACEUTICAL PREPARATION BASED ON LYS PLASMINOGEN |
CS277138B6 (en) | 1990-11-06 | 1992-11-18 | Masarykova Nemocnice S Polikli | Process for preparing transmissible factor industrially |
SU1752187A3 (en) | 1990-12-11 | 1992-07-30 | А.Б.Сигалов | Method for delipidation of lyophilized lipoproteins of high density from human blood serum |
WO1992013495A1 (en) | 1991-02-07 | 1992-08-20 | Fibratek, Inc. | Fibrinogen based adhesive |
WO1992014360A1 (en) | 1991-02-15 | 1992-09-03 | Cryopharm Corporation | Method of lyophilization and reconstitution of mixtures of nucleated non-mammalian cells and blood matter |
US5242792A (en) | 1991-02-25 | 1993-09-07 | The United States Of America As Represented By The Secretary Of The Navy | Method for the preservation of red blood cells by lyophilization using glycerol or inositol with disaccharides |
US5262325A (en) | 1991-04-04 | 1993-11-16 | Ibex Technologies, Inc. | Method for the enzymatic neutralization of heparin |
JP3140797B2 (en) | 1991-04-26 | 2001-03-05 | 生化学工業株式会社 | Stabilized chondroitinase ABC, preservation method thereof and therapeutic agent |
RU2028133C1 (en) | 1991-08-05 | 1995-02-09 | Чередниченко Лев Павлович | Method for treating chemical burns of cornea |
RU2011202C1 (en) | 1992-03-26 | 1994-04-15 | Научно-производственное объединение "Вектор" | Stabilizing composition for preparing of lyophilized positive control sera used in test-systems for assay of specific antibodies to viruses and micro- organisms |
DE69333928T2 (en) | 1992-04-30 | 2006-08-17 | Probitas Pharma Inc., Los Angeles | IMPROVED SOLUBILIZATION AND STABILIZATION OF THE FACTOR VIII COMPLEX |
EP0642301B1 (en) | 1992-05-29 | 2003-03-12 | The University Of North Carolina At Chapel Hill | Pharmaceutically acceptable fixed-dried human blood platelets |
DK83092D0 (en) | 1992-06-24 | 1992-06-24 | Unes As | PROCEDURE FOR THE EXTRACTION OF THROMBIN |
JPH06192118A (en) | 1992-09-28 | 1994-07-12 | Wisconsin Alumni Res Found | Composition of medicine containing botulinus toxin for curing abnormally hypersensitive muscle dyskinesia and its preparation |
CA2124690C (en) | 1992-10-02 | 2007-09-11 | Thomas Osterberg | Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer |
CN1091315A (en) | 1992-10-08 | 1994-08-31 | E·R·斯奎布父子公司 | Fibrin sealant compositions and using method thereof |
US5411893A (en) | 1993-03-15 | 1995-05-02 | Difco Laboratories | Dry slide for diagnostic tests |
JP3292760B2 (en) | 1993-04-22 | 2002-06-17 | テルモ株式会社 | Blood collection tube and method for producing the same |
US5747268A (en) | 1993-04-22 | 1998-05-05 | Dade International Inc. | Tumor marker control |
RU2090165C1 (en) | 1993-05-14 | 1997-09-20 | Чередниченко Михаил Львович | Method for treatment of cornea injuries |
JPH06336828A (en) | 1993-05-28 | 1994-12-06 | Nippon Light Metal Co Ltd | Scaffold device for building |
US5409826A (en) | 1993-06-08 | 1995-04-25 | Coulter Corporation | Preserved, non-infectious control cells prepared by the modulation or modification of normal cells |
US5695764A (en) | 1993-06-11 | 1997-12-09 | Bontemps; Raymond | Manufacturing and preservation procedure for fresh plant cosmetic substances free of preservative and applied in the frozen state |
JP3142192B2 (en) | 1993-07-20 | 2001-03-07 | ポーラ化成工業株式会社 | Blood lipid improving agent and composition containing the same |
US5362442A (en) | 1993-07-22 | 1994-11-08 | 2920913 Canada Inc. | Method for sterilizing products with gamma radiation |
NZ248309A (en) | 1993-08-02 | 1995-07-26 | Nat Deer Horn Ltd | Powdered deer blood and manufacture thereof |
GB9322316D0 (en) | 1993-10-29 | 1993-12-15 | Poller Leon | Control calibrant plasmas |
RU2090166C1 (en) | 1993-12-06 | 1997-09-20 | Чередниченко Михаил Львович | Method for treating descementocele |
WO1995015763A1 (en) | 1993-12-08 | 1995-06-15 | Universite De Montreal | Process for the preparation of serum and platelet growth factors extract |
JP2831258B2 (en) | 1994-02-03 | 1998-12-02 | 全国農業協同組合連合会 | Freezing method of bovine embryo |
EP0752097A4 (en) | 1994-03-07 | 1997-12-10 | Coulter Corp | Covalent immobilized antibodies on polymeric beads |
FR2717782B1 (en) | 1994-03-22 | 1996-06-21 | Stephane Ibled | Protective packaging for transfer bag containing a liquid, such as a blood product. |
JPH07270405A (en) | 1994-03-29 | 1995-10-20 | Sekisui Chem Co Ltd | Manufacture of blood collecting tube |
HU218280B (en) | 1994-04-26 | 2000-07-28 | Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes | |
ATE202633T1 (en) | 1994-04-28 | 2001-07-15 | Dade Behring Inc | CALIBRATOR FOR PROTHROMBIN TIME ASSAY |
DK0762897T3 (en) | 1994-06-02 | 2003-07-21 | Elan Drug Delivery Ltd | Process for preventing protein / peptide aggregation by rehydration or thawing |
JP3365091B2 (en) | 1994-09-30 | 2003-01-08 | 日本油脂株式会社 | Lipid extraction method |
US5464471A (en) | 1994-11-10 | 1995-11-07 | Whalen Biomedical Inc. | Fibrin monomer based tissue adhesive |
IT1267880B1 (en) | 1994-11-15 | 1997-02-18 | Veeger Leander | LINE FOR THE SEMI-AUTOMATIC FEEDING OF ENLARGING / DRYING MACHINES, DRYERS AND PALISSONERS OF INDUSTRIAL LEATHER. |
US5585007A (en) | 1994-12-07 | 1996-12-17 | Plasmaseal Corporation | Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant |
GB9424732D0 (en) | 1994-12-08 | 1995-02-08 | Common Services Agency | Heat treated blood plasma proteins |
JP3219181B2 (en) | 1995-01-10 | 2001-10-15 | 東洋紡績株式会社 | Stabilization method of cholesterol oxidase |
US7253262B2 (en) | 1995-01-19 | 2007-08-07 | Quandrant Drug Delivery Limited | Dried blood factor composition comprising trehalose |
FR2729932B1 (en) | 1995-01-30 | 1997-04-18 | Steril Packing System Lab | SACHET FOR PACKAGING OR STERILIZATION OF PRODUCTS |
JP3543144B2 (en) | 1995-03-11 | 2004-07-14 | 国際試薬株式会社 | Formulation for clinical test |
US7112320B1 (en) | 1995-06-07 | 2006-09-26 | Andre Beaulieu | Solid wound healing formulations containing fibronectin |
US5690963A (en) | 1995-06-30 | 1997-11-25 | The United States Of America As Represented By The Secretary Of The Navy | Freeze dried red blood cells |
JPH0920687A (en) | 1995-07-03 | 1997-01-21 | Nippon Telegr & Teleph Corp <Ntt> | Thawing solution of freeze-dry blood |
ES2157446T3 (en) | 1995-07-12 | 2001-08-16 | Univ Montreal | SERODIAGNOSTIC ELISA OF THE PLEURONEUMONIA SEROTIPOS 1, 9 AND 11, OF THE PIG. |
CA2227448C (en) | 1995-07-26 | 2008-02-05 | Universite De Montreal | Elisa serodiagnosis of pig pleuropneumonia serotypes 5a and 5b |
CA2184132C (en) | 1995-09-21 | 2011-03-15 | Kristina J. Hennessy | An adjuvanted vaccine which is substantially free of non-host albumin |
US5736313A (en) | 1995-10-20 | 1998-04-07 | The United States Of America As Represented By The Secretary Of The Navy | Method of lyophilizing platelets by incubation with high carbohydrate concentrations and supercooling prior to freezing |
RU2121364C1 (en) | 1995-11-03 | 1998-11-10 | Государственный научный центр вирусологии и биотехнологии "Вектор" | Method of preparing a recombinant alfa-2-interferon-base lyophilized preparation against viral diseases in carnivore animals |
USRE38431E1 (en) | 1995-12-01 | 2004-02-17 | The American National Red Cross | Methods of production and use of liquid formulations of plasma proteins |
JPH09222427A (en) | 1995-12-11 | 1997-08-26 | Sekisui Chem Co Ltd | Blood inspection container |
US5770700A (en) | 1996-01-25 | 1998-06-23 | Genetics Institute, Inc. | Liquid factor IX formulations |
US5834418A (en) | 1996-03-20 | 1998-11-10 | Theratechnologies, Inc. | Process for the preparation of platelet growth factors extract |
US5891393A (en) | 1996-04-09 | 1999-04-06 | The University Of North Carolina At Chapel Hill | Method for the microbial decontamination of blood platelets |
JP2000509374A (en) | 1996-04-19 | 2000-07-25 | アルファ セラピュティック コーポレイション | Method for virus inactivation of lyophilized blood proteins |
US5928213A (en) | 1996-05-13 | 1999-07-27 | B. Braun Medical, Inc. | Flexible multiple compartment medical container with preferentially rupturable seals |
JP4059299B2 (en) | 1996-05-22 | 2008-03-12 | ソニー株式会社 | Silicon thin film, silicon single crystal particle group, semiconductor device, and flash memory cell |
WO1997046883A1 (en) | 1996-06-03 | 1997-12-11 | Universite De Montreal | Elisa serodiagnosis of pig pleuropneumonia serotypes 4 and 7 |
US6060233A (en) | 1996-06-14 | 2000-05-09 | Biostore New Zealand, Ltd | Methods for the lyophilization of platelets, platelet membranes or erythrocytes |
US5750330A (en) | 1996-06-19 | 1998-05-12 | Litron Laboratories | Method and composition for lyophilizing red blood cells |
US5891736A (en) | 1996-06-21 | 1999-04-06 | Bayer Corporation | Reagents and methods for releasing and measuring lead ions from biological matrices |
RU2080865C1 (en) | 1996-07-08 | 1997-06-10 | Станислав Людвигович Люблинский | Method of hemoglobin preparing |
JPH1045616A (en) | 1996-08-02 | 1998-02-17 | Shionogi & Co Ltd | Sustained release preparation for injection |
WO1998008099A1 (en) | 1996-08-19 | 1998-02-26 | SHAKER, Ghassan, I. | Use of molt4 cd69 expression to determine the presence and activity of interferon inhibitors |
DE19634313A1 (en) | 1996-08-24 | 1998-02-26 | Behringwerke Ag | Method for stabilizing platelets |
JPH10108907A (en) | 1996-10-08 | 1998-04-28 | Toyobo Co Ltd | Membrane for hemocatharsis, its preparation and module for hemocatharsis |
US5968831A (en) | 1996-10-29 | 1999-10-19 | Coulter International Corp. | Cell control used to confirm enzymatic activity |
US5837519A (en) | 1996-11-21 | 1998-11-17 | Bayer Corporation | Dry-heat viral inactivation under controlled moisture conditions |
US5919935A (en) | 1996-11-22 | 1999-07-06 | The Ohio State Research Foundation | Psoralen sensitizers for viral inactivation |
JPH10165480A (en) | 1996-12-13 | 1998-06-23 | Material Eng Tech Lab Inc | Freeze-dried matter vessel and manufacture thereof |
US6358678B1 (en) | 1998-02-11 | 2002-03-19 | The United States Of America As Represented By The Secretary Of The Navy | Applications of reversible crosslinking and co-treatment in stabilization and viral inactivations of erythrocytes |
KR100197297B1 (en) | 1997-02-25 | 1999-06-15 | 김철한 | Processing method for powdering of a snapping turtle |
ES2277376T3 (en) | 1997-04-08 | 2007-07-01 | Universite De Montreal | SERODIAGNOSIS THROUGH ELISA OF THE PORCINE PLEURONEUMONIA OF SEROTYPE 2. |
EP0896824A1 (en) | 1997-08-05 | 1999-02-17 | Octapharma Ag | A universally applicable blood plasma |
US6177282B1 (en) | 1997-08-12 | 2001-01-23 | Mcintyre John A. | Antigens embedded in thermoplastic |
CA2242693C (en) | 1997-09-04 | 2002-09-17 | Becton, Dickinson And Company | Additive formulation and method of use thereof |
CN1210267A (en) | 1997-09-04 | 1999-03-10 | 中国生物工程公司 | Reagent box for determining plasma protein A related to pregnancy by enzyme combination quantity |
WO1999024034A1 (en) | 1997-11-07 | 1999-05-20 | Children's Medical Center Corporation | USE OF DIVALENT CATIONS FOR INHIBITING ERYTHROCYTE DEHYDRATION $i(IN VIVO) |
AT407484B (en) | 1997-11-12 | 2001-03-26 | Bio Prod & Bio Eng Ag | MEDICINES FOR PROMOTING Wound Healing |
US5985582A (en) | 1997-12-09 | 1999-11-16 | Sigma-Aldrich Co. | Thrombin-based assay for antithrombin III |
AU744025B2 (en) | 1997-12-09 | 2002-02-14 | Sigma-Aldrich Co. | Plasma reference |
RU2193868C2 (en) | 1998-03-26 | 2002-12-10 | Российский научный центр "Восстановительная травматология и ортопедия" им. акад. Г.А.Илизарова | Method for stimulation of reparative osteogenesis |
AU3475099A (en) | 1998-04-06 | 1999-10-25 | Cornell Research Foundation Inc. | Composition for tissue welding and method of use |
US6139878A (en) | 1998-04-27 | 2000-10-31 | Aventis Behring, Llc | Method for preparing a diafiltered stabilized blood product |
US6194394B1 (en) | 1998-07-01 | 2001-02-27 | Sigma-Aldrich Co. | Coagulation controls for prothrombin time (PT) and activated partial thromboplastin time (APTT) assays |
EP1100494A1 (en) | 1998-07-30 | 2001-05-23 | Novopharm Biotech, Inc. | Pharmaceutically composition comprising an aqueous solution of paclitaxel and albumin |
US6358236B1 (en) | 1998-08-06 | 2002-03-19 | Baxter International Inc. | Device for reconstituting medicaments for injection |
JP2000070241A (en) | 1998-08-31 | 2000-03-07 | Nissho Corp | Vacuum blood collection tube for rapid coagulation |
KR100302949B1 (en) | 1998-09-24 | 2001-11-22 | 이영현 | Blood Treatment Method of Meat Animals |
DE19850074A1 (en) | 1998-10-30 | 2000-05-04 | Dade Behring Marburg Gmbh | Stabilization of biological liquids by adding sterol esters |
WO2000047187A1 (en) | 1999-02-11 | 2000-08-17 | Kinetana Inc. | Serum albumin-based parenteral formulations of polyene macrolides |
US20050158856A1 (en) | 1999-04-20 | 2005-07-21 | Edelson Richard L. | Methods for producing functional antigen presenting dendritic cells using biodegradable microparticles for delivery of antigenic materials |
EP1171163A1 (en) | 1999-04-27 | 2002-01-16 | Antibody Systems, Inc. | Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders |
US20010031721A1 (en) | 1999-05-05 | 2001-10-18 | Chandra Webb | Highly concentrated, lyophilized, and liquid factor IX formulations |
US6472162B1 (en) | 1999-06-04 | 2002-10-29 | Thermogenesis Corp. | Method for preparing thrombin for use in a biological glue |
CN1093173C (en) | 1999-06-19 | 2002-10-23 | 宋开泉 | Papain blood group diagnose reagent prepn. method |
RU2155602C1 (en) | 1999-11-30 | 2000-09-10 | Оао "Куантум Сатис" | Insulin-containing drug for oral using and method of its preparing |
AU2431800A (en) | 1999-12-15 | 2001-06-25 | Pentapharm Ag | Hematological assay and reagent |
DE19963420A1 (en) | 1999-12-28 | 2001-07-12 | Sebo Gmbh | Obtaining biological components from body fluids |
EP1113269B1 (en) | 1999-12-29 | 2006-10-18 | PerkinElmer Life Sciences, Inc. | Test tray, kit and methods for screening body fluids of newborns by tandem mass spectrometry |
WO2001058266A1 (en) | 2000-02-10 | 2001-08-16 | The Regents Of The University Of California | Therapeutic platelets and methods |
DE10006662A1 (en) | 2000-02-15 | 2001-08-23 | Antigen Produktions Gmbh | Sample vessel for stabilizing and isolating nucleic acid, contains a lytic solution that stabilizes nucleic acid and a solid phase that binds it, especially for sampling whole blood |
DE50013987D1 (en) | 2000-02-29 | 2007-03-08 | Owen Holding Ltd | METHOD FOR THE PRODUCTION OF A BIOACTIVE SUBSTANCE FROM BLOOD SERUM |
DE10015310A1 (en) | 2000-03-28 | 2001-10-04 | Bayer Ag | Active ingredient combinations with insecticidal and acaricidal properties |
AU2001263200A1 (en) | 2000-05-17 | 2001-11-26 | The American National Red Cross | Gamma irradiation of protein-based pharmaceutical products |
AU2001260658A1 (en) | 2000-06-01 | 2001-12-11 | Hokkaido Technology Licensing Office Co., Ltd. | Method of preparing small hepatocytes preservable in freeze-dried state and method of preserving the same in freeze-dried state |
JP2002029977A (en) | 2000-07-13 | 2002-01-29 | Tsubota:Kk | Serum for treating dry eye and method for producing the same |
JP2002052067A (en) | 2000-08-09 | 2002-02-19 | Kyowa Medex Co Ltd | Use-time medicine dissolution instrument, container for use-time dissolution type kit preparation, and use-time dissolution type kit preparation |
HU230538B1 (en) | 2000-08-14 | 2016-11-28 | Ortho Mcneil Pharmaceutical, Inc. | Substituted pyrazoles and pharmaceutical compositions containing them |
FR2813395B1 (en) | 2000-08-28 | 2003-01-24 | Stago Diagnostica | METHOD OF IN VITRO DETERMINATION OF SOLUBLE FIBRIN BY GENERATION OF SPECIFIC DEGRADATION PRODUCTS |
FR2814239B1 (en) | 2000-09-21 | 2003-01-03 | Biopep Sa Soc | ENZYMATIC ASSAY TEST WITH OPTICAL READING DIAGNOSIS |
US20020146409A1 (en) | 2001-01-30 | 2002-10-10 | Herring Steven W. | Methods for stabilizing lyophilized blood proteins |
KR100446856B1 (en) | 2001-04-14 | 2004-09-04 | 주식회사 콧데 | anti pityrosporum ovale IgY and its uses |
CN1207004C (en) | 2001-04-18 | 2005-06-22 | 马建川 | Freeze-dried plasma without blood group and its preparation method |
HUP0101713A2 (en) | 2001-04-27 | 2003-02-28 | István Horváth | Process for the preparation of artificial blood |
BG64922B1 (en) | 2001-05-14 | 2006-09-29 | Веселин ИВАНОВ | Sorbent for toxic gases capturing |
JP4268347B2 (en) | 2001-05-30 | 2009-05-27 | 富士フイルム株式会社 | Control serum for dry analytical elements |
US8741335B2 (en) | 2002-06-14 | 2014-06-03 | Hemcon Medical Technologies, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan |
RU2197267C1 (en) | 2001-07-05 | 2003-01-27 | Эпштейн Олег Ильич | Medicinal agent and method of treatment of asthenic states |
US20030031584A1 (en) | 2001-08-10 | 2003-02-13 | Wilson Burgess | Methods for sterilizing biological materials using dipeptide stabilizers |
JP2003055257A (en) | 2001-08-10 | 2003-02-26 | Nihon Pharmaceutical Co Ltd | Stable blood coagulation factor xiii preparation |
JP2003055256A (en) | 2001-08-10 | 2003-02-26 | Nihon Pharmaceutical Co Ltd | Stable blood coagulation factor xiii preparation |
WO2003020116A2 (en) | 2001-08-31 | 2003-03-13 | University Of North Carolina At Chapel Hill | Fixed-dried red blood cells |
US20030068416A1 (en) | 2001-09-24 | 2003-04-10 | Wilson Burgess | Method of lyophylization to reduce solvent content and enhance product recovery |
JP4024506B2 (en) | 2001-09-28 | 2007-12-19 | 達夫 隈崎 | Control method for anticancer drug perfusion apparatus |
CN1157194C (en) | 2001-09-29 | 2004-07-14 | 罗才良 | Active deer blood powder capsule |
CN1156282C (en) | 2001-10-19 | 2004-07-07 | 罗才良 | Active goat blood powder capsule |
DE10151343A1 (en) * | 2001-10-22 | 2003-05-08 | Vita 34 Ag | Bag system for the cryopreservation of body fluids |
US6989891B2 (en) | 2001-11-08 | 2006-01-24 | Optiscan Biomedical Corporation | Device and method for in vitro determination of analyte concentrations within body fluids |
JP2003144523A (en) | 2001-11-13 | 2003-05-20 | Material Eng Tech Lab Inc | Plural-chamber container |
NL1019873C2 (en) | 2002-01-31 | 2003-08-04 | Harimex Bv | Method for preparing a blood plasma powder, and applications thereof. |
CN1376520A (en) | 2002-02-28 | 2002-10-30 | 华兰生物工程股份有限公司 | Process for deactivating freeze dried human plasma virus |
DE10211227A1 (en) | 2002-03-13 | 2003-10-02 | Aventis Behring Gmbh | Process for the reconstitution of lyophilized proteins |
JP3712989B2 (en) | 2002-04-01 | 2005-11-02 | 株式会社エイアンドティー | Method for producing freeze-dried plasma |
WO2003082310A1 (en) | 2002-04-03 | 2003-10-09 | General Nutrition Investment Company | Composition and method for the treatment or prevention of il-1 mediated disorders |
CN1187616C (en) | 2002-04-18 | 2005-02-02 | 中国科学院水生生物研究所 | Method for preparing quick estrogenoid toxicity detecting test piece |
US7569184B2 (en) | 2002-04-23 | 2009-08-04 | Home Access Health Corporation | Quantitative analysis of a biological sample of unknown quantity |
CN1410537A (en) | 2002-04-25 | 2003-04-16 | 华兰生物工程股份有限公司 | Production method of freeze dried human zymoplasm |
JP2003339346A (en) | 2002-05-23 | 2003-12-02 | Tookaibiken:Kk | Health food preparation and method for producing the same |
KR20070118200A (en) | 2002-06-07 | 2007-12-13 | 프로메테안 라이프사이언시즈, 인코포레이티드 | Sterilization, stabilization and preservation of functional biologics |
AU2007205748B2 (en) | 2002-06-07 | 2009-11-26 | Promethean Lifesciences, Inc. | Sterilization, stabilization and preservation of functional biologics |
JP2004049493A (en) | 2002-07-18 | 2004-02-19 | Jms Co Ltd | Hemodialyzer and hemodialyzer control program |
CN1162160C (en) | 2002-10-11 | 2004-08-18 | 上海新兴医药股份有限公司 | Low-condensing agent universal freeze-dried blood plasma |
CN1250718C (en) | 2002-12-05 | 2006-04-12 | 兆科药业(合肥)有限公司 | Chromatography purification process of viper venom blood clotting enzyme |
CN1270731C (en) | 2002-12-23 | 2006-08-23 | 江苏康缘药业股份有限公司 | Composition for adjusting blood fat and preparing method thereof |
EP1435241A1 (en) | 2002-12-30 | 2004-07-07 | Kyokuto Pharmaceutical Industrial Co. Ltd | Method for stabilizing blood, serum, or plasma specimen and container containing ph buffer agent |
KR100503629B1 (en) | 2002-12-31 | 2005-07-26 | 박동기 | The preparation method of the young antlers of the deer, deer blood or deer horns and the functional food using thereof |
US7041635B2 (en) | 2003-01-28 | 2006-05-09 | In2Gen Co., Ltd. | Factor VIII polypeptide |
FR2853551B1 (en) | 2003-04-09 | 2006-08-04 | Lab Francais Du Fractionnement | STABILIZING FORMULATION FOR IMMUNOGLOBULIN G COMPOSITIONS IN LIQUID FORM AND LYOPHILIZED FORM |
JP2004313708A (en) * | 2003-04-17 | 2004-11-11 | Fukoku Co Ltd | Flexible drug container sealing solid drug therein and its manufacturing method |
RU2242759C1 (en) | 2003-06-02 | 2004-12-20 | Нижегородская государственная медицинская академия | Method for predicting multiple sclerosis |
CN1220512C (en) | 2003-07-08 | 2005-09-28 | 河北鹿宝生物工程有限公司 | Capsule with pilose deerhorn blood and gingeng and its preparation method |
FR2857267B1 (en) | 2003-07-09 | 2006-03-10 | Lab Francais Du Fractionnement | STABILIZING AND SOLUBILIZING FORMULATION FOR CRYOPRECIPITABLE PROTEINS. |
US7348399B2 (en) | 2003-08-29 | 2008-03-25 | Louisiana Tech University Foundation, Inc. | Nanofabricated polypeptide multilayer films, coatings, and microcapsules |
US8450079B2 (en) | 2003-10-31 | 2013-05-28 | Immunetics, Inc. | Method for detecting bacteria |
US8296071B2 (en) | 2004-03-15 | 2012-10-23 | Terumo Bct Biotechnologies, Llc | Methods for uniformly treating biological samples with electromagnetic radiation |
US20050221414A1 (en) | 2004-03-31 | 2005-10-06 | Katalin Varadi | Kit for measuring the thrombin generation in a sample of a patient's blood or plasma |
US7678888B2 (en) | 2004-04-21 | 2010-03-16 | Albert Einstein College Of Medicine Of Yeshiva University | Stable oxidation resistant powdered hemoglobin, methods of preparing same, and uses thereof |
WO2005120591A1 (en) | 2004-06-07 | 2005-12-22 | I.M.T. Interface Multigrad Technology Ltd. | Method for sterilization of biological preparations |
RU2266542C1 (en) | 2004-06-15 | 2005-12-20 | Дальневосточный государственный медицинский университет | Method for assay of dehydration degree |
KR100624013B1 (en) | 2004-06-25 | 2006-09-19 | 주식회사 녹십자홀딩스 | Pharmaceutical preparation of recombinant factor ? lyophilized without albumin as a stabilizer |
TWI270375B (en) | 2004-06-29 | 2007-01-11 | Cheng-Yao Su | A method for preserving platelets outside a living body |
US20060004189A1 (en) | 2004-07-02 | 2006-01-05 | James Gandy | Compositions for treating wounds and processes for their preparation |
KR20060005770A (en) | 2004-07-14 | 2006-01-18 | 주식회사 에이.비.아이 | Preparation of water soluble heme-iron polypeptide complex from animal whole blood or clotted blood |
EP1619459B2 (en) | 2004-07-22 | 2012-12-12 | Telstar Technologies, S.L. | Device for loading and unloading containers |
JP2006036749A (en) | 2004-07-26 | 2006-02-09 | Kei Cho | Active functional agent of ostrich blood |
KR100631188B1 (en) | 2004-07-29 | 2006-10-09 | (주)새우리 | Liquid manure and Method for manufacturing the same |
US7811558B2 (en) | 2004-08-12 | 2010-10-12 | Cellphire, Inc. | Use of stabilized platelets as hemostatic agent |
RU2273026C1 (en) | 2004-08-18 | 2006-03-27 | Государственное образовательное учреждение высшего профессионального образования "Нижегородская Государственная Медицинская академия" МЗ РФ (ГОУ ВПО НижГМА) | Method for diagnosing the cases of hyperparaproteinemia |
CN1745627A (en) | 2004-09-10 | 2006-03-15 | 丁庆 | Ostrich blood and active function of related products |
US20070110817A1 (en) | 2004-10-18 | 2007-05-17 | Owen Holding Ltd. | Biological active blood serum obtained by electrostimulation |
JP5087815B2 (en) | 2004-10-27 | 2012-12-05 | コニカミノルタホールディングス株式会社 | Organic EL device |
WO2006054519A1 (en) | 2004-11-17 | 2006-05-26 | Kyowa Medex Co., Ltd. | Standard item for fractional determination of component of lipoprotein |
CN1267340C (en) | 2005-01-04 | 2006-08-02 | 武汉理工大学 | Supersonic wave evoked bovine serum albumin mold plate method for preparing bar-shaped hydroxyapatite |
US7565808B2 (en) | 2005-01-13 | 2009-07-28 | Greencentaire, Llc | Refrigerator |
JP2008531553A (en) | 2005-02-25 | 2008-08-14 | メディジーンズ カンパニー リミテッド | Pharmaceutical composition for the treatment of Avellino corneal dystrophy comprising plasma or serum |
US20080193386A1 (en) | 2005-03-24 | 2008-08-14 | Medigenes Co., Ltd | Compositions for Treating Alopecia or Promoting Hair Growth |
CN1281161C (en) | 2005-06-20 | 2006-10-25 | 甘肃祁连山生物科技开发有限责任公司 | Anti-fatigue health-care food and production thereof |
FR2887883B1 (en) | 2005-06-29 | 2007-08-31 | Lab Francais Du Fractionnement | PROCESS FOR SEPARATING FIBRINOGEN PROTEINS, FACTOR XIII AND BIOLOGICAL GLUE OF SOLUBILIZED PLASMA FRONTION AND PREPARATION OF LYOPHILIZED CONCENTRATES OF SAID PROTEINS |
US20070014780A1 (en) | 2005-07-13 | 2007-01-18 | Statseal | Storage-stable human fibrinogen solutions |
WO2008048229A2 (en) | 2005-08-12 | 2008-04-24 | Department Of The Army | Stabilized lyophilized blood platelets |
US7879332B2 (en) | 2005-09-01 | 2011-02-01 | Plasma Technologies, Llc | Ultra-high yield intravenous immune globulin preparation |
WO2007035583A1 (en) | 2005-09-19 | 2007-03-29 | University Of Maryland, Baltimore | Lyophilization of hemoglobin solutions |
DK1942868T5 (en) | 2005-11-01 | 2024-01-08 | Wyeth Llc | Sodium chloride solution for drug reconstitution or dilution |
US8153061B2 (en) | 2005-11-23 | 2012-04-10 | Siemens Healthcare Diagnostics Inc. | Storage and supply system for clinical solutions used in an automatic analyzer |
CN100469359C (en) | 2005-12-31 | 2009-03-18 | 抚顺市九九鹿业有限责任公司 | Deer blood powder capsule and preparation process thereof |
US8277837B2 (en) | 2006-01-11 | 2012-10-02 | Entegrion, Inc. | Hemostatic textile |
AU2012205238B2 (en) | 2006-01-11 | 2015-04-16 | Entegrion, Inc. | Hemostatic textile |
JP2007197353A (en) | 2006-01-25 | 2007-08-09 | Univ Of Tsukuba | Liver regeneration promoter |
RU2314527C1 (en) | 2006-03-21 | 2008-01-10 | Гоу Впо "Нижегородская Государственная Медицинская Академия Росздрава" (Гоу Впо "Нижгма Росздрава") | Method for establishing uremic genesis of polyneuropathy |
NZ573111A (en) | 2006-04-28 | 2012-02-24 | Cambridge Scient Pty Ltd | Cox-2 inhibitor |
CN101385855B (en) | 2006-05-19 | 2011-11-16 | 成都军区疾病预防控制中心昆明军事医学研究所 | Fine purification method of polyvalent anti-snake venom freeze-dry blood serum |
JP2007317768A (en) * | 2006-05-24 | 2007-12-06 | Matsushita Electric Ind Co Ltd | Optical semiconductor device and manufacturing method therefor |
BRPI0712910B8 (en) | 2006-05-26 | 2021-05-25 | Baxter Int | multi-component system for an injectable bone augmentation composition, and, injectable bone augmentation composition |
CN101347617B (en) | 2006-06-02 | 2011-04-06 | 成都军区疾病预防控制中心军事医学研究所 | Refined polyvalent anti-snake poison lyophilized blood serum and using method |
EP1870649A1 (en) | 2006-06-20 | 2007-12-26 | Octapharma AG | Lyophilisation targetting defined residual moisture by limited desorption energy levels |
CN1931025A (en) | 2006-07-17 | 2007-03-21 | 许海军 | Eel blood health product and its making process |
KR100767541B1 (en) | 2006-08-10 | 2007-10-17 | 오수연 | Distilled liquor comprising powder of deer's blood and method producing theirof |
RU2325655C9 (en) | 2006-08-10 | 2008-11-27 | Общество с ограниченной ответственностью Научно-производственное объединение "Диагностические системы" | Immune-enzyme test system for hepatitis b virus surface antigen detection and method of hepatitis b virus surface antigen detection |
US20080063697A1 (en) | 2006-09-08 | 2008-03-13 | Bedard Robert L | Use of Unactivated Calcium Exchanged Zeolites in Hemostatic Devices and Products |
CA2664956C (en) | 2006-10-05 | 2018-09-18 | Eureka S.A. | Systems and methods for automated wireless authorization for entry into a geographic area |
CA2664415C (en) | 2006-10-05 | 2014-12-16 | Tyco Healthcare Group Lp | Flexible endoscopic stitching devices |
US8529958B2 (en) | 2006-10-17 | 2013-09-10 | Carmell Therapeutics Corporation | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
KR100857273B1 (en) | 2006-10-20 | 2008-09-08 | 이연원 | Method for breeding a pig to inject serum of pig |
RU2322243C1 (en) | 2006-10-20 | 2008-04-20 | Наталья Юрьевна Костюкова | Pharmaceutical composition for treatment of cornea injury |
US10195230B2 (en) | 2006-12-14 | 2019-02-05 | Mcneese State University | Blood product from crocodylian species as a feed supplement for weanling pigs and poultry hatchlings |
WO2008108549A1 (en) | 2007-03-05 | 2008-09-12 | Jootae Kim | Method on long-term structural preservation of hemocyte utilizing cellular lyophilization technique |
RU2332666C1 (en) | 2007-04-16 | 2008-08-27 | Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Росздрава" (ГОУ ВПО "НИЖГМА РОСЗДРАВА") | Method of drug or powerful chemical intoxication diagnostics |
UA26543U (en) | 2007-05-21 | 2007-09-25 | Inst Problems Of Cryobiology & Cryomedicine | Method for obtaining freeze-dried serum of human cord blood |
KR100908742B1 (en) | 2007-05-22 | 2009-07-22 | 김신익 | Manufacturing method of functional supplement containing organic germanium |
CN100531723C (en) | 2007-07-17 | 2009-08-26 | 锦州奥鸿药业有限责任公司 | Calf serum protein-removing extract for injection and its preparation method |
CN101152211A (en) | 2007-09-28 | 2008-04-02 | 大连医科大学附属第一医院 | Dachengqi tang animal blood plasma freeze-dried powder and method for preparing the same |
WO2009049318A2 (en) | 2007-10-12 | 2009-04-16 | Bakaltcheva Irina B | Freeze-dried plasma formats for the trauma care field |
CN101167745B (en) | 2007-11-02 | 2010-06-02 | 中国人民解放军军事医学科学院野战输血研究所 | Small molecular sugar stable buffer used for blood platelet frozen-dried preservation |
CN101433553B (en) | 2007-12-07 | 2011-08-17 | 吉林康乃尔药业有限公司 | Method for preparing deproteinized extract of calf blood and freeze-dried powder thereof |
CN101461939B (en) | 2007-12-19 | 2012-01-04 | 中国科学院大连化学物理研究所 | Angiotensin converting enzyme inhibitor and preparation thereof |
JP5252909B2 (en) | 2007-12-26 | 2013-07-31 | アズビル株式会社 | Measurement control device and storage element protection method |
CN101285086B (en) | 2007-12-29 | 2012-05-23 | 青岛蔚蓝生物集团有限公司 | Feather products, processing technology and use thereof |
CN100529742C (en) | 2008-01-11 | 2009-08-19 | 陕西科技大学 | Reagent kit for detecting fibrinolytic enzyme fibrinolytic activity |
RU2357252C1 (en) | 2008-02-26 | 2009-05-27 | Татьяна Александровна Колесова | Chronic cholecystitis remission diagnostic method |
CN101980714A (en) | 2008-03-31 | 2011-02-23 | 奥古斯蒂努斯·巴德 | Method and composition for regenerating tissue with the aid of stem or bone marrow cells |
CN101299029A (en) | 2008-05-30 | 2008-11-05 | 广西科学院 | Preparation for detecting organophosphorus pesticide residual test paper and its use method |
JP5521235B2 (en) | 2008-06-12 | 2014-06-11 | HOYA Technosurgical株式会社 | High-strength fibrin molded body and artificial ligament |
CN101310728A (en) | 2008-07-17 | 2008-11-26 | 沈阳斯佳科技发展有限公司 | Free protein blood of pig injection and use thereof |
CN102149813B (en) | 2008-09-12 | 2015-05-27 | 能波公司 | Apparatus and method for dehydrating biological materials with freezing and microwaving |
CN102209896B (en) | 2008-11-07 | 2014-04-02 | 日立化成工业株式会社 | Blood serum or blood plasma separation method |
NZ593190A (en) | 2008-11-07 | 2013-01-25 | Baxter Int | Factor viii formulations |
CN100584942C (en) | 2008-12-09 | 2010-01-27 | 中国人民解放军南京军区南京总医院 | Method for quickly separating human total blood or suspended red cell supernatant |
CN101416985A (en) | 2008-12-10 | 2009-04-29 | 青岛海生肿瘤医院 | Extraction method of arca extract freeze-drying powder |
CN101756013B (en) | 2008-12-24 | 2013-05-22 | 代祥 | Preparation method for an easily absorbed high protein blood powder |
EA020194B1 (en) | 2009-02-02 | 2014-09-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Lyophilised dabigatran |
RU2426548C2 (en) | 2009-02-13 | 2011-08-20 | Виталий Александрович Шестаков | Pharmaceutical composition and method of obtaining antioncologic fractions of blood serum (af bs) |
US8697747B2 (en) | 2009-03-05 | 2014-04-15 | The Uab Research Foundation | Enhancing coagulation or reducing fibrinolysis |
US8187475B2 (en) | 2009-03-06 | 2012-05-29 | Biomet Biologics, Llc | Method and apparatus for producing autologous thrombin |
CN102448475A (en) | 2009-04-09 | 2012-05-09 | 恩特格利昂公司 | Spray-dried blood products and methods of making same |
JP2010266086A (en) | 2009-05-12 | 2010-11-25 | Soka Univ | Freeze-drying device, freeze-drying method for sample, device for preparing sample for electron microscope including freeze-drying device and method of preparing sample for electron microscope |
TWI358264B (en) | 2009-05-22 | 2012-02-21 | Hsu Yin Kuo | Processes for producing blood powder |
CN101579356A (en) | 2009-06-05 | 2009-11-18 | 武汉理工大学 | Deproteinated calf blood ingredient brain targeting nanosphere and preparation method thereof |
US8734854B2 (en) | 2009-07-09 | 2014-05-27 | Orogen Biosciences Inc. | Process for removing growth factors from platelets |
KR101106015B1 (en) | 2009-07-20 | 2012-01-17 | 차의과학대학교 산학협력단 | Pharmaceutical composition for preventing or treating diabetic wound |
CN101618120A (en) | 2009-07-21 | 2010-01-06 | 罗文礼 | Health care product containing active ostrich blood component and capable of invigorating primordial Qi and resisting fatigue and preparation method thereof |
US8313654B2 (en) | 2009-08-21 | 2012-11-20 | The United States Of America, As Represented By The Secretary Of Agriculture | Methods for flocculating suspensions using biobased renewable flocculants |
US20120141595A1 (en) | 2009-08-25 | 2012-06-07 | Tissuetech, Inc. | Umbilical cord amniotic membrane products |
US20110142885A1 (en) | 2009-09-16 | 2011-06-16 | Velico Medical, Inc. | Spray-dried human plasma |
US8407912B2 (en) | 2010-09-16 | 2013-04-02 | Velico Medical, Inc. | Spray dried human plasma |
RU2540480C2 (en) | 2009-11-24 | 2015-02-10 | Грифольс Терапьютикс Инк. | Methods, compositions and sets for lyophilisation |
US9211283B2 (en) | 2009-12-11 | 2015-12-15 | Biolitec Pharma Marketing Ltd | Nanoparticle carrier systems based on human serum albumin for photodynamic therapy |
JP5763880B2 (en) | 2009-12-11 | 2015-08-12 | 国立大学法人 新潟大学 | Regenerative treatment materials |
CN101893628A (en) | 2009-12-30 | 2010-11-24 | 中国疾病预防控制中心寄生虫病预防控制所 | Kit for detecting circulating antigen indirect hemagglutination of schistosomiasis and manufacturing method thereof |
KR101157096B1 (en) | 2010-01-20 | 2012-06-22 | 정석방 | Composition for relieving hangover containing Bulnesia sarmienti extracts |
CN101766252A (en) | 2010-01-21 | 2010-07-07 | 辽源市麒鸣生物技术综合开发有限公司 | Sheep blood high-activity immune globulin concentrate and preparation method thereof |
EP2348319A1 (en) | 2010-01-21 | 2011-07-27 | DIAGNOSTICA STAGO (Société par Actions Simplifiée) | Method for adjusting the coagulation time in calibrator or control plasmas |
FR2955927B1 (en) | 2010-02-01 | 2012-04-06 | Alcatel Lucent | DEVICE AND METHOD FOR CONTROLLING A DEHYDRATION OPERATION DURING A LYOPHILIZATION TREATMENT |
CN101893639B (en) | 2010-02-11 | 2013-10-30 | 上海蓝怡科技有限公司 | Method for stabilizing activity of alpha-hydroxybutyricdehydrogenaseand lactic dehydrogenase of quality-control serum |
CN101843335B (en) | 2010-03-24 | 2012-06-13 | 内蒙古圣鹿源生物科技股份有限公司 | Method for preparing antler freeze-dried powder by ultrasonic cracking |
CN102106872B (en) | 2010-03-26 | 2014-06-18 | 北京洪源澳达生物技术发展有限公司 | Crocodile blood freeze-dried powder, and preparation method and application thereof |
EP2371342A1 (en) | 2010-04-01 | 2011-10-05 | Siemens Healthcare Diagnostics Products GmbH | Device for storing and metering a solution |
CN101816789B (en) | 2010-04-08 | 2012-09-05 | 成都军区疾病预防控制中心军事医学研究所 | Lyophilized viper antivenin and preparation method thereof |
CN101830979B (en) | 2010-04-16 | 2012-06-13 | 中南民族大学 | Method for separating and purifying serum albumin by using liquid-solid extraction system |
ES2545893T3 (en) | 2010-04-20 | 2015-09-16 | Octapharma Ag | New stabilizing agent for pharmaceutical proteins |
US20110265384A1 (en) | 2010-04-29 | 2011-11-03 | Panduit Corp. | Vertical Cable Manager Door |
CN101833009A (en) | 2010-04-29 | 2010-09-15 | 浙江康特生物科技有限公司 | Double antibody complex retinol-binding protein assay kit |
CN101843289B (en) | 2010-04-30 | 2012-12-12 | 秦皇岛益尔动物科技有限公司 | Enzymolysis processing method of whole blood polypeptide albumen powder |
CN102240310B (en) | 2010-05-13 | 2013-03-06 | 郭国康 | Blood-sugar-reducing composition and preparation method thereof |
WO2011150284A2 (en) | 2010-05-26 | 2011-12-01 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
CN101879333A (en) | 2010-06-17 | 2010-11-10 | 吉林大学 | Preparation method of acellular organism stent |
US20130126370A1 (en) | 2010-06-17 | 2013-05-23 | David DiLiberto | Multi-compartment container with frangible seal and external means for applying opening force between compartments |
CN101899110B (en) | 2010-07-16 | 2012-08-08 | 浙江大学 | Method for separating immune globulin IgY(delta Fc) from goose blood |
CN102337252A (en) | 2010-07-19 | 2012-02-01 | 天津宝迪农业科技股份有限公司 | Method for extracting superoxide dismutase (SOD) from pig blood |
CN101900712B (en) | 2010-07-21 | 2012-10-10 | 江苏省原子医学研究所 | Pharmacokinetic testing method of Exendin-4 |
EP2415461B1 (en) | 2010-07-24 | 2012-10-31 | Roche Diagnostics GmbH | Stabilization of interleukin 6 in serum based solutions |
FR2963556A3 (en) | 2010-08-03 | 2012-02-10 | Sephar Soc D Etudes Pharma | Composition, useful to e.g. treat rosacea, comprises alpha-bisabolol, alpha-tocopherol, hyaluronic acid, polyuronides heteropolysaccharides, extract of Cucurbita Pepo, flavonoids extract of Aesculus hippocastanum L., escin, and shea butter |
US8430970B2 (en) | 2010-08-09 | 2013-04-30 | Lam Research Corporation | Methods for preventing corrosion of plasma-exposed yttria-coated constituents |
FR2963737B1 (en) | 2010-08-16 | 2013-04-05 | Etat Francais Ministere De La Defense Service De Sante Des Armees | PROCESS FOR THE LYOPHILIZATION OF BLOOD PLASMA |
PT2606147E (en) | 2010-08-20 | 2015-01-14 | Cytonet Gmbh & Co Kg | Method for isolating urea while removing objectionable co2 |
EP2611384A4 (en) | 2010-09-03 | 2015-04-15 | Gen Hospital Corp | Blood vessel grafts for repair, reconstruction and filler materials |
CN101948630B (en) | 2010-09-10 | 2013-02-27 | 合肥工业大学 | Method for preparing carboxyhemoglobin from blood of livestock and poultry |
CN101957364A (en) | 2010-09-19 | 2011-01-26 | 李勇 | Preparation method of lyophilization type platelet antigen spectrum cells |
US8900864B2 (en) | 2010-09-21 | 2014-12-02 | Nordrhein-Wesfalen Krankenhausbetriebsgesellschaft Bad Oeynhausen mbH | Stabilized leukocytes and their use |
RU2442984C1 (en) | 2010-10-08 | 2012-02-20 | Виктория Глебовна Фирсова | Method for predicting the acute pancreatitis outcome |
CN101971972A (en) | 2010-10-09 | 2011-02-16 | 上海阿敏生物技术有限公司 | Preparation method for simultaneously extracting Tibet barley serum and Tibet barley dietary fiber |
CN102012433B (en) | 2010-11-05 | 2015-02-04 | 中国农业科学院哈尔滨兽医研究所 | Avian influenza virus H9 subtype positive blood serum and negative blood serum standard substances and preparation methods thereof |
CN102050876A (en) | 2010-11-05 | 2011-05-11 | 中国农业科学院哈尔滨兽医研究所 | Positive-serum and negative-serum standard substance of avian influenza virus H5N1 subtype Re-5 strain and preparation method thereof |
CN102000022A (en) | 2010-11-23 | 2011-04-06 | 郑州大学 | Recombined bifunctional plasmin freeze-drying preparation for injection and preparation method thereof |
CN102512418B (en) | 2010-12-06 | 2014-11-26 | 山东绿叶制药有限公司 | Pantoprazole sodium drug composition and preparation method thereof |
CN102008504A (en) | 2010-12-09 | 2011-04-13 | 协和干细胞基因工程有限公司 | Blood plasma product for clinical transfusion and preparation method thereof |
IL210162A0 (en) | 2010-12-21 | 2011-03-31 | Omrix Biopharmaceuticals | Viral inactivated platelet extract, use and preparation thereof |
CN102093385B (en) | 2010-12-30 | 2013-03-27 | 天津药物研究院 | Schiff base compounds as well as preparation method and application of Schiff base compounds |
WO2012092712A1 (en) | 2011-01-07 | 2012-07-12 | 无锡圆容生物医药股份有限公司 | Lyophilized nanometer particle powder preparation comprising recombinant albumin prepared from human plasma |
CN102078306A (en) | 2011-01-11 | 2011-06-01 | 无锡圆容生物医药股份有限公司 | Taxol nanoparticle freeze-drying preparation containing recombinant human serum albumin |
RU2455014C1 (en) | 2011-01-19 | 2012-07-10 | Федеральное казённое учреждение здравоохранения "Российский научно-исследовательский противочумный институт "Микроб" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФКУЗ РосНИПЧИ "Микроб "Роспотребнадзора) | Method for producing lyophilised preparation of laky blood |
WO2012098358A1 (en) | 2011-01-20 | 2012-07-26 | Biopharma Technology Ltd | Freeze drying method |
WO2012101109A1 (en) | 2011-01-24 | 2012-08-02 | Cell Med Research Gmbh | Native dendritic cells |
PL2668262T3 (en) | 2011-01-28 | 2018-04-30 | University Of Miami | Expanded utility of red cell-derived microparticles (rmp) for treatment of bleeding |
CN103649751B (en) | 2011-02-15 | 2017-03-29 | 海默索尼克斯有限公司 | For assessing the devices, systems and methods of hemostasis |
CN102207504A (en) | 2011-03-23 | 2011-10-05 | 北京华创远航科技有限公司 | Enzyme-linked immunosorbent assay kit, and preparation method thereof |
EP2508892A1 (en) | 2011-04-04 | 2012-10-10 | Siemens Healthcare Diagnostics Products GmbH | Controls and kit for thrombocyte activity tests |
RU2456602C1 (en) | 2011-04-07 | 2012-07-20 | Государственное образовательное учреждение высшего професионального образования "Нижегородская государственная медицинская академия" Министерства здравоохранения и социального развития Российской Федерации (ГОУ ВПО НижГМА Минздравсоцразвития России) | Diagnostic technique in malignant solid tumours and remote metastases |
EP2697645A1 (en) | 2011-04-15 | 2014-02-19 | VivaBioCell SpA | Immunodiagnostic method for diagnosing auto-immune systemic sclerosis (ssc) and systemic lupus erythematosus (sle) |
US9011846B2 (en) | 2011-05-02 | 2015-04-21 | Biomet Biologics, Llc | Thrombin isolated from blood and blood fractions |
CN102229670A (en) | 2011-05-10 | 2011-11-02 | 苏州瑞蓝博中药技术开发有限公司 | Method for extracting immune globulin from yak blood |
CN102210854B (en) | 2011-05-13 | 2013-04-17 | 杭州普济医药技术开发有限公司 | Method for carrying out virus inactivation on pig fibrinogens through freeze-drying and heating |
CN102250238A (en) | 2011-05-16 | 2011-11-23 | 西北农林科技大学 | Method for synthesizing swainsonine antigen |
WO2012159075A1 (en) | 2011-05-19 | 2012-11-22 | Seattle Biomedical Research Institute | Bioprobe compositions and their methods of use |
KR101200423B1 (en) | 2011-05-20 | 2012-11-12 | 한국과학기술연구원 | High sensitive analytical method of estrogen metabolites in urine and blood obtained from postmenopausal women |
CN102228683B (en) | 2011-06-21 | 2013-03-13 | 南岳生物制药有限公司 | Method for preparing freeze-dried human blood coagulation factor VIII |
CN102241767B (en) | 2011-06-22 | 2013-07-10 | 河南省医药科学研究院 | Extraction method of bovine serum albumin |
RU2463063C1 (en) | 2011-07-06 | 2012-10-10 | Федеральное государственное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова" Министерства здравоохранения и социального развития Российской Федерации | Method for preparing agent for stimulation of skin repair regeneration |
CN102866220B (en) | 2011-07-08 | 2014-07-23 | 中国科学院大连化学物理研究所 | Chemical derivation-based detection method for hemolymph metabolin of migratory locust |
KR20130009161A (en) | 2011-07-14 | 2013-01-23 | 김재병 | Stem cell culture medium with the active ingredient in the treatment and symptoms of atopic dermatitis hwayong complete composition |
CN102258780B (en) | 2011-07-15 | 2013-06-05 | 北京新华联协和药业有限责任公司 | Lyophilized mite allergen vaccine and preparation method thereof |
DE102011054474B4 (en) | 2011-07-20 | 2014-02-13 | Stratec Biomedical Ag | System for stabilization, storage and storage of a nucleic acid |
US10723497B2 (en) | 2014-11-03 | 2020-07-28 | Vanrx Pharmasystems Inc. | Apparatus and method for monitoring and controlling the filling of a container with a pharmaceutical fluid in an aseptic environment |
CN102357259A (en) | 2011-07-28 | 2012-02-22 | 王珊珊 | Bioprotein sponge and preparation method thereof |
ES2369945B1 (en) | 2011-07-29 | 2012-10-15 | Eduardo Anitua Aldecoa | PROCEDURE FOR OBTAINING A COMPOSITION CONTAINING GROWTH FACTORS FROM A BLOOD COMPOUND, AND COMPOSITION OBTAINABLE BY SUCH PROCEDURE. |
CN102908368A (en) | 2011-08-02 | 2013-02-06 | 天津济命生生物科技有限公司 | Preparation method of virus lyophilized preparation |
CN102319425B (en) | 2011-08-05 | 2013-06-12 | 霍红梅 | Wound healing agent and radix astragali composite freeze-dried platelet gel kit for preparing wound healing agent |
CN102274493B (en) | 2011-08-30 | 2013-08-21 | 董萍 | Bleeding-stopping, inflammation-diminishing and pain-relieving nano emulsion for use in minimally invasive beauty treatment therapy and preparation method thereof |
CN102435743B (en) | 2011-09-15 | 2014-10-15 | 北京健平九星生物医药科技有限公司 | ELISA detection kit and preparation method thereof |
CN102426240B (en) | 2011-09-19 | 2014-10-15 | 北京健平金星生物科技有限公司 | Enzyme-linked detection kit and preparation method thereof |
WO2013042868A1 (en) | 2011-09-20 | 2013-03-28 | Republic Of Korea(Management : Rural Development Administration) | Method of obtaining silkworm gland-derived hydrolysate |
EP2574350A1 (en) | 2011-09-29 | 2013-04-03 | Biorigen S.r.l | Medical uses of lyophilized polymeric membranes containing blood derivatives |
KR101333457B1 (en) | 2011-09-29 | 2013-11-26 | 영남대학교 산학협력단 | Method for proliferating BHK-21 cell using gender-specific serum |
KR102135484B1 (en) | 2011-10-11 | 2020-07-20 | 백스터 인터내셔널 인코포레이티드 | Hemostatic compositions |
CN102327288B (en) | 2011-10-17 | 2012-11-14 | 济南环肽医药科技有限公司 | Blood platelet freeze-dried powder preparation for injection and preparation method thereof |
CN102327289B (en) | 2011-10-17 | 2012-10-03 | 济南环肽医药科技有限公司 | Erythrocyte freeze-dried powder preparation for injection and preparation method thereof |
US9394353B2 (en) | 2011-10-18 | 2016-07-19 | Csl Limited | Method for improving the stability of purified factor VIII after reconstitution |
CN102524812A (en) | 2011-10-29 | 2012-07-04 | 山东好当家海洋发展股份有限公司 | Freeze-drying duck blood silk noodle food and preparation method thereof |
CN102507934B (en) | 2011-11-02 | 2014-02-26 | 集美大学 | Time-resolved fluoroimmunoassay (TRFIA) of Klebsiella oxytoca |
DE102011117628B4 (en) | 2011-11-04 | 2015-10-22 | Martin Christ Gefriertrocknungsanlagen Gmbh | Freeze-drying plant with a loading and unloading device |
CN102525954B (en) | 2011-11-09 | 2013-06-05 | 济南环肽医药科技有限公司 | Lyophilized emulsion preparation for injection of levo-gossypol and acetate of levo-gossypol |
CN102426258B (en) | 2011-11-11 | 2014-03-05 | 中国兽医药品监察所 | Positive serum national standard substance used for newcastle disease hemagglutination inhibition test and preparation method thereof |
KR101429522B1 (en) | 2011-11-15 | 2014-09-25 | 한양대학교 산학협력단 | Method for extracting extracelluar matrix from placenta and scaffold for skin wound treatment using material extracted by the same |
CN102363634A (en) | 2011-11-16 | 2012-02-29 | 厦门出入境检验检疫局检验检疫技术中心 | Method for preparing pyrethroid pesticide polyclonal antibody |
EA029443B1 (en) | 2011-11-23 | 2018-03-30 | Селл Терапи Лимитед | Pharmaceutical composition comprising platelet lysate |
CN102746396A (en) | 2011-12-07 | 2012-10-24 | 扬州大学 | Method for extracting and transferring bovine serum albumin by preparing Cm-s-Cm type surfactant into reverse micelle |
WO2013085502A1 (en) | 2011-12-07 | 2013-06-13 | Biolife, L.L.C. | Composition and method for arresting blood flow and for forming a persistent antimicrobial barrier |
RU2478958C1 (en) | 2012-01-11 | 2013-04-10 | ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ ОБРАЗОВАТЕЛЬНОЕ УЧРЕЖДЕНИЕ ВЫСШЕГО ПРОФЕССИОНАЛЬНОГО ОБРАЗОВАНИЯ "НИЖЕГОРОДСКАЯ ГОСУДАРСТВЕННАЯ МЕДИЦИНСКАЯ АКАДЕМИЯ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ И СОЦИАЛЬНОГО РАЗВИТИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ (ГБОУ ВПО "НижГМА" МИНЗДРАВСОЦРАЗВИТИЯ РОССИИ) | Diagnostic technique for decompensated type 2 diabetes mellitus |
US9682104B2 (en) | 2012-01-26 | 2017-06-20 | Jadi Cell Llc | Lyophilized platelet lysates |
RU2492867C1 (en) | 2012-02-09 | 2013-09-20 | Закрытое акционерное общество "Алтайвитамины" | Biologically active additive |
CN102590496A (en) | 2012-02-13 | 2012-07-18 | 高建芳 | Rapid snake wound identification method |
CN102600508B (en) | 2012-02-14 | 2014-03-19 | 上海交通大学医学院附属上海儿童医学中心 | Porcine arterial vacuum lyophilization acellular matrix, as well as preparation method and application thereof |
CN102590529A (en) | 2012-02-16 | 2012-07-18 | 邵伟 | Kit for detecting PCDH10 (Protocadherin10) in serum by TRFIA (Time Resolved Fluorescence Immunoassay method) |
US20130251695A1 (en) | 2012-02-28 | 2013-09-26 | Ganeden Biotech, Inc. | Cosmetic Compositions |
CN102579737B (en) | 2012-02-29 | 2014-12-10 | 泰山医学院 | Dragon blood nano medicament crystallized preparation and preparation method thereof |
CN102552154B (en) | 2012-03-19 | 2013-10-16 | 成都师创生物医药科技有限公司 | Albumin nanoparticle preparation for anthracycline antitumor antibiotic oleic acid compound |
KR20140145176A (en) | 2012-03-30 | 2014-12-22 | 다우 아그로사이언시즈 엘엘씨 | Methods for preparing 3-substituted-6-trifluoromethyl pyridines and methods for using 6-trichloromethyl halogenated pyridines |
CN102600231A (en) | 2012-03-30 | 2012-07-25 | 常熟市常福有机复合肥有限公司 | Anti-fatigue nutrient and preparation method thereof |
CN102645358B (en) | 2012-04-06 | 2014-09-10 | 上海蓝怡科技有限公司 | Preparation method of water-soluble cholesterol lyophilized product derived from serum |
CN102614219A (en) | 2012-04-06 | 2012-08-01 | 湖南紫光古汉南岳制药有限公司 | Method for preparing human prothrombin complex with high yield |
CN102600074B (en) | 2012-04-16 | 2014-07-30 | 浙江磐谷药源有限公司 | Injection carbazochrome sodium sulfonate suspension and preparation method thereof |
CN102628869B (en) | 2012-04-19 | 2014-04-02 | 上海蓝怡科技有限公司 | Preparation for improving freeze-drying stability of alpha fetal protein antibody |
CN102688200B (en) | 2012-05-09 | 2014-03-26 | 广州帝奇医药技术有限公司 | Plant anti-cancer targeting nano-preparation, and preparation method thereof |
CN102697581B (en) | 2012-05-16 | 2014-11-12 | 上海交通大学医学院附属上海儿童医学中心 | Method for constructing tissue engineering blood vessel |
CN102692514A (en) | 2012-06-21 | 2012-09-26 | 厦门大学 | Blood 25-hydroxy vitamin D3 adenocarcinoma assay kit and preparation method thereof |
CN102754848A (en) | 2012-07-16 | 2012-10-31 | 大连奥泰药业股份有限公司 | Method for producing alcoholic beverage freeze-dried preservative deer blood |
CN102854322A (en) | 2012-07-31 | 2013-01-02 | 吴克 | Vascular endothelial growth factor (VEGF) receptor enzyme linked diagnosis kit and preparation method thereof |
US8904664B2 (en) * | 2012-08-15 | 2014-12-09 | Mimedx Group, Inc. | Dehydration device and methods for drying biological materials |
CN102793053A (en) | 2012-08-22 | 2012-11-28 | 天津宝迪农业科技股份有限公司 | Technology for producing high-protein content and low-ash content plasma protein powder |
RU2526799C2 (en) | 2012-09-06 | 2014-08-27 | Виталий Александрович Шестаков | Pharmaceutical composition and method for preparing antiviral fractions (antivirus-c) |
US9731017B2 (en) | 2012-09-13 | 2017-08-15 | W. L. Gore & Associates, Inc. | Polytetrafluoroethylene co-polymer emulsions |
CN102866255B (en) | 2012-09-13 | 2014-12-24 | 莫水晶 | Kit for detecting fungus (1-3)-beta-D glucan in human body fluid and application method of kit |
CN102879560A (en) | 2012-10-22 | 2013-01-16 | 周胜利 | Method for accurately and rapidly detecting antigens and antibodies in human serum in trace mode |
CN102908321A (en) | 2012-11-07 | 2013-02-06 | 海南中化联合制药工业股份有限公司 | Albumin conjugated taxol nanoparticle freeze-dried preparation and preparation method thereof |
CN102988974B (en) | 2012-12-14 | 2015-05-20 | 山东滨州沃华生物工程有限公司 | Method for preparing porcine pseudorabies live vaccine by using passage CEF (chicken embryo fibroblast) |
CN103076455B (en) | 2012-12-26 | 2015-08-26 | 上海奥普生物医药有限公司 | Quantitative detection serum amyloid A protein kit and Synthesis and applications thereof |
CN103054816A (en) | 2012-12-27 | 2013-04-24 | 蚌埠丰原涂山制药有限公司 | Aprotinin freeze-dried powder and preparation method thereof |
CN103039693B (en) | 2013-01-09 | 2014-04-30 | 合肥工业大学 | Preparation method of modified livestock and poultry plasma protein powder |
CN103007280B (en) | 2013-01-18 | 2014-02-19 | 辽宁益康生物股份有限公司 | Piglet colibacillosis lyophilized serum immunoglobulin preparation and preparation process thereof |
CN103113456B (en) | 2013-03-05 | 2014-07-16 | 中国药科大学 | Stiff silkworm polypeptide with antiplatelet aggregation activity as well as preparation method and application of stiff silkworm polypeptide |
ITMI20131016A1 (en) | 2013-06-19 | 2014-12-20 | I M A Ind Macchine Automatic He S P A | FEEDING SYSTEM IN A LIOFILIZING MACHINE FOR THE PHARMACEUTICAL SECTOR |
CN203572189U (en) | 2013-10-24 | 2014-04-30 | 上海凛马机械科技有限公司 | Freeze dryer partition plate mechanism driven by electric push rod |
JP6869455B2 (en) * | 2014-03-28 | 2021-05-12 | 北海道公立大学法人 札幌医科大学 | Manufacturing method of cell filling container, cell filling container, and sealing device |
JP6305870B2 (en) | 2014-08-21 | 2018-04-04 | ニチコン株式会社 | Power switching circuit |
KR20180012242A (en) * | 2015-03-10 | 2018-02-05 | 뉴 헬스 사이언시즈 인코포레이티드 | Oxygen reduction disposable kit, device and method of use thereof |
US9696284B2 (en) | 2015-06-10 | 2017-07-04 | Thermo Fisher Scientific Oy | Extraction column |
CN105342850B (en) * | 2015-11-13 | 2019-10-18 | 重庆莱美药业股份有限公司 | Single needle medicine mixer, hard double nip and transfusion flexible bag |
AU2017230806B2 (en) | 2016-03-10 | 2021-06-24 | Arthrex, Inc. | Systems and methods for preparing a thrombin serum |
ITUA20161823A1 (en) | 2016-03-18 | 2017-09-18 | I M A Industria Macch Automatiche S P A In Sigla Ima S P A | APPARATUS FOR LOADING AND DOWNLOADING A LILOR FILTER. |
WO2017177104A1 (en) | 2016-04-07 | 2017-10-12 | Velico Medical, Inc. | Reconstitution solution for spray-dried plasma |
EP3290064B1 (en) | 2016-09-06 | 2018-10-24 | Fritz Ruck Ophthalmologische Systeme GmbH | System for measuring an amount of liquid in an elastic bag |
DK3335695T3 (en) * | 2016-12-15 | 2020-04-20 | Upm Kymmene Corp | Process for freeze-drying hydrogel comprising nanofibrillar cellulose, freeze-dried medical hydrogel comprising nanofibrillar cellulose and hydrogel comprising nanofibrillar cellulose |
GB2564481B (en) | 2017-07-14 | 2019-10-23 | 4D Pharma Leon S L U | Process |
WO2020185909A2 (en) | 2019-03-14 | 2020-09-17 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
-
2018
- 2018-10-09 CN CN201880064085.6A patent/CN111295094A/en active Pending
- 2018-10-09 JP JP2020540696A patent/JP7110360B2/en active Active
- 2018-10-09 US US16/154,976 patent/US10793327B2/en active Active
- 2018-10-09 WO PCT/US2018/054943 patent/WO2019074886A1/en unknown
- 2018-10-09 EP EP18793137.3A patent/EP3694322A1/en active Pending
- 2018-10-09 CA CA3078625A patent/CA3078625C/en active Active
-
2020
- 2020-09-02 US US17/010,083 patent/US11634257B2/en active Active
-
2022
- 2022-05-11 JP JP2022077855A patent/JP7227417B2/en active Active
Patent Citations (176)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1441570A (en) | 1920-08-12 | 1923-01-09 | Fitzgerald Frederic Will Vesey | Process for the preparation of commercial products from blood |
US1504225A (en) | 1921-05-19 | 1924-08-12 | Fitzgerald Frederic Will Vesey | Process for the preparation of commercial products from blood |
GB450146A (en) | 1934-01-31 | 1936-07-06 | Sharp & Dohme Inc | Biologically active substances and process of producing the same |
US2704075A (en) | 1952-03-10 | 1955-03-15 | Baxter Don Inc | Flexible plastic container |
GB748784A (en) | 1953-06-12 | 1956-05-09 | Edwards & Co London Ltd W | Improvements in or relating to vacuum freezing and/or vacuum freeze drying methods and apparatus |
US2767117A (en) | 1953-10-22 | 1956-10-16 | Crawley John Frederick | Poultry virus vaccine products and method of preparing the same |
GB814491A (en) | 1956-01-17 | 1959-06-03 | American Home Prod | Lipid mobiliser |
US3229813A (en) | 1959-05-08 | 1966-01-18 | Johnson & Johnson | Sterile package |
US3187750A (en) | 1963-01-15 | 1965-06-08 | Baxter Laboratories Inc | Multiple bag blood storage unit |
US3247957A (en) | 1964-08-17 | 1966-04-26 | Hospital Supply And Dev Compan | Sterile packaging and the like |
US3468471A (en) | 1965-06-24 | 1969-09-23 | Fritz Linder | Bacteriaproof plastic bag for articles to be sterilized |
US3375824A (en) | 1965-07-08 | 1968-04-02 | Air Force Usa | Self-contained plasma administration pack |
GB1206033A (en) | 1967-01-24 | 1970-09-23 | Grace W R & Co | Improvements in or relating to methods of processing food |
US3466249A (en) | 1967-02-13 | 1969-09-09 | Baxter Laboratories Inc | Blood serum reference standard for multi-automated analytical procedures |
US3537189A (en) | 1968-10-14 | 1970-11-03 | Virtis Co Inc | Removable tray and cover lift assembly |
US3571940A (en) | 1969-04-21 | 1971-03-23 | Cenco Medical Health Supply Co | Thermal cassette |
US3574950A (en) | 1969-06-12 | 1971-04-13 | Jospeh L Dantoni | Lyophilizing apparatus |
US3607858A (en) | 1970-03-31 | 1971-09-21 | American Cyanamid Co | Process for preparing lyophilized human blood proteins such as gamma globulin in the presence of a nonionic surfactant |
US3945523A (en) | 1973-06-25 | 1976-03-23 | Applied Bioscience | Freeze storage container system |
GB1486787A (en) | 1973-10-23 | 1977-09-21 | Behringwerke Ag | Process for stabilizing protein containing liquids |
US4035924A (en) | 1974-09-11 | 1977-07-19 | Societe D'assistance Technique Pour Produits Nestle S.A. | Freeze-drying of solid, liquid or paste-like products |
US4056484A (en) | 1974-12-31 | 1977-11-01 | Behringwerke Aktiengesellschaft | Stable blood plasma, process for preparing it and its use as comparative plasma in coagulation tests |
DE2617742A1 (en) | 1974-12-31 | 1977-06-30 | Behringwerke Ag | Stabilisation of freeze-dried blood plasma - by storage in an atmos. contg. carbon dioxide |
US3964865A (en) | 1975-01-30 | 1976-06-22 | Sigma Chemical Company | Lyophilized human hemoglobin standard for colorimetric determination of total hemoglobin |
US4001944A (en) | 1975-08-25 | 1977-01-11 | Parke, Davis & Company | Freeze-drying process |
US4134943A (en) | 1975-12-16 | 1979-01-16 | Boehringer Mannheim Gmbh | Production of porous tablets |
US4109396A (en) | 1976-12-06 | 1978-08-29 | Fts Systems, Inc. | Method and apparatus for an improved shelf and tray assembly for a freeze dryer |
US4218321A (en) | 1977-08-05 | 1980-08-19 | Agency Of Industrial Science & Technology | Device for removal of excess water from blood |
US4650678A (en) | 1982-02-04 | 1987-03-17 | Behringwerke Aktiengesellschaft | Readily dissolvable lyophilized fibrinogen formulation |
US4664913A (en) | 1982-05-24 | 1987-05-12 | Xoma Corporation | Method for treating plasma for transfusion |
US4664913B1 (en) | 1982-05-24 | 1990-01-30 | Xoma Corp | |
US4813210A (en) | 1985-09-27 | 1989-03-21 | Nissho Corporation | Radiation-sterilized, packaged medical device |
JPS6336828A (en) | 1986-07-30 | 1988-02-17 | Showa Denko Kk | Production of dried particulate material and vacuum freeze dryer |
US4730460A (en) | 1987-02-09 | 1988-03-15 | Castleton, Inc. | Ultra - rapid plasma freezing with halocarbon heat transfer liquids |
EP0284249A1 (en) | 1987-03-13 | 1988-09-28 | Interferon Sciences, Inc. | Lyophilized lymphokine composition |
US4994057A (en) | 1987-09-24 | 1991-02-19 | Miles Inc. | Sterilizable system for blood storage |
US4902287A (en) | 1987-09-24 | 1990-02-20 | Miles Inc. | Sterilizable system for blood storage |
US4904641A (en) | 1988-01-12 | 1990-02-27 | Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte | Method of inactivating reproducible filterable pathogens in blood plasma products |
EP0335682A1 (en) | 1988-03-31 | 1989-10-04 | Hercules Incorporated | Water-permeable controlled atmosphere packaging device from cellophane and microporous film |
US5425951A (en) | 1988-05-18 | 1995-06-20 | Cryopharm Corporation | Method of reconstituting lyophilized cells |
US5759774A (en) | 1988-05-18 | 1998-06-02 | Cobe Laboratories, Inc. | Method of detecting circulating antibody types using dried or lyophilized cells |
US5171661A (en) | 1988-05-18 | 1992-12-15 | Cryopharm Corporation | Medium for lyophilization of erythrocytes |
US5178884A (en) | 1988-05-18 | 1993-01-12 | Cryopharm Corporation | Lyophilized and reconstituted red blood cell compositions |
US5340592A (en) | 1988-05-18 | 1994-08-23 | Cobe Laboratories, Inc. | Lyophilization of erythrocytes |
US5309649A (en) | 1988-05-26 | 1994-05-10 | Boehringer Mannheim Gmbh | Process and container for freeze drying under sterile conditions |
EP0343596B1 (en) | 1988-05-26 | 1992-03-04 | Roche Diagnostics GmbH | Container for freeze drying under sterile conditions |
US5045446A (en) | 1988-08-26 | 1991-09-03 | Cryopharm Corporation | Lyophilization of cells |
US5648206A (en) | 1988-08-26 | 1997-07-15 | Cobe Laboratories, Inc. | Lyophilization of cells |
US4874690A (en) | 1988-08-26 | 1989-10-17 | Cryopharm Corporation | Lyophilization of red blood cells |
US5043261A (en) | 1989-04-10 | 1991-08-27 | Cryopharm Corporation | Lyophilized and reconstituted red blood cell and hemosome compositions |
US5213814A (en) | 1989-04-10 | 1993-05-25 | Cryopharm Corporation | Lyophilized and reconstituted blood platelet compositions |
US4973327A (en) | 1989-11-01 | 1990-11-27 | Cryopharm | Blood bag for lyophilization |
US5114004A (en) | 1990-02-14 | 1992-05-19 | Material Engineering Technology Laboratory Inc. | Filled and sealed, self-contained mixing container |
US5059036A (en) | 1990-04-27 | 1991-10-22 | Kapak Corporation | Vented pouch arrangement and method |
US5849473A (en) | 1991-02-15 | 1998-12-15 | Cobe Laboratories, Inc. | Method of lyophilization of mammalian sperm cells |
US5257983A (en) | 1991-04-12 | 1993-11-02 | Cryopharm Corporation | Blood bag for lyophilization |
US5514123A (en) | 1993-04-01 | 1996-05-07 | Abbott Laboratories | Sterile formed, filled and sealed flexible container |
US5656498A (en) | 1994-02-22 | 1997-08-12 | Nippon Telegraph And Telephone Corporation | Freeze-dried blood cells, stem cells and platelets, and manufacturing method for the same |
WO1995027180A1 (en) | 1994-04-04 | 1995-10-12 | W.L. Gore & Associates, Inc. | Improved method for minimizing contamination of freeze-dried products |
WO1996029556A1 (en) | 1995-03-18 | 1996-09-26 | The Wellcome Foundation Limited | Freeze-drying process and apparatus |
WO1996031748A1 (en) | 1995-04-07 | 1996-10-10 | W.L. Gore & Associates, Inc. | A freeze-drying bag and method for minimizing contamination of freeze-dried products |
US5551781A (en) | 1995-04-21 | 1996-09-03 | Wilkes; Kenneth R. | Sterilizable container and method of fabrication |
US6007529A (en) | 1996-04-10 | 1999-12-28 | Pharmacia & Upjohn Ab | Containers for parenteral fluids |
US6398771B1 (en) | 1996-04-10 | 2002-06-04 | Pharmacia Ab | Containers for parenteral fluids |
US6132454A (en) | 1996-05-03 | 2000-10-17 | Hotties Thermal Packs Limited | Heat pack |
US6148536A (en) | 1996-06-10 | 2000-11-21 | Nippon Telegraph And Telephone Corporation | Two-fluid nozzle and device employing the same nozzle for freezing and drying liquid containing biological substances |
US6221575B1 (en) | 1997-02-07 | 2001-04-24 | Quadrant Holdings Cambridge Ltd. | Methods for producing dried storage-stable platelets and compositions obtained thereby |
DE19729778A1 (en) | 1997-07-11 | 1999-01-21 | Blutspendedienst Der Drk Lande | Process for the preparation of virus-inactivated biological fluids |
US5853388A (en) | 1997-08-21 | 1998-12-29 | Semel; David | Intravenous bag with separate compartment |
US5946931A (en) | 1998-02-25 | 1999-09-07 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Evaporative cooling membrane device |
EP1087990B1 (en) | 1998-06-23 | 2004-09-22 | Shanbrom Technologies, LLC | Method and apparatus for the production of purified plasma proteins |
WO2000036353A1 (en) | 1998-12-12 | 2000-06-22 | University Of Strathclyde | Method for drying a material in a container having one or more pierced holes |
US6199297B1 (en) | 1999-02-01 | 2001-03-13 | Integrated Biosystems, Inc. | Lyophilization apparatus and methods |
US6381870B1 (en) | 2000-01-07 | 2002-05-07 | Milliken & Company | Bag for home dry cleaning process |
US20020035354A1 (en) | 2000-06-21 | 2002-03-21 | The Procter & Gamble Company | Absorbent barrier structures having a high convective air flow rate and articles made therefrom |
US7179951B2 (en) | 2000-06-21 | 2007-02-20 | The Procter & Gamble Company | Absorbent barrier structures having a high convective air flow rate and articles made therefrom |
US6608237B1 (en) | 2000-08-03 | 2003-08-19 | Kimberly-Clark Worldwide, Inc. | High-strength, stabilized absorbent article |
US6517526B1 (en) * | 2000-12-29 | 2003-02-11 | Yehuda Tamari | Container for lyophilizing biological products |
US6773425B1 (en) | 2000-12-29 | 2004-08-10 | Yehuda Tamari | Container for biological products requiring cellular stasis |
US6869901B2 (en) | 2001-02-20 | 2005-03-22 | Pactiv Corporation | Protective drainage wraps |
US7202341B2 (en) | 2001-04-18 | 2007-04-10 | Northfield Laboratories, Inc. | Stabilized hemoglobin solutions |
US20030065149A1 (en) | 2001-04-18 | 2003-04-03 | Northfield Laboratories | Stabilized hemoglobin solutions |
US7435795B2 (en) | 2001-04-18 | 2008-10-14 | Northfield Laboratories, Inc. | Stabilized hemoglobin solutions |
US7048709B2 (en) | 2001-06-12 | 2006-05-23 | Macopharma | Bag provided with means for the temporary association of a filter |
EP1407780B1 (en) | 2001-07-10 | 2013-05-01 | The Chemo-Sero-Therapeutic Research Institute | Pharmaceutically stable hemostatic compositions |
US6981337B2 (en) | 2002-01-30 | 2006-01-03 | Reckitt Benckiser (Uk) Limited | Device for absorbing water vapor |
US7175614B2 (en) | 2002-10-17 | 2007-02-13 | Baxter International Inc. | Peelable seal |
US7422726B2 (en) | 2002-10-23 | 2008-09-09 | Blood Cell Storage, Inc. | Integrated container for lyophilization, rehydration and processing of biological materials |
US20040081588A1 (en) | 2002-10-23 | 2004-04-29 | Hammerstedt Roy H. | Integrated container for lyophilization, rehydration and processing of biological materials |
US20060216687A1 (en) | 2002-12-24 | 2006-09-28 | Odilio Alves-Filho | Reconstitutable dried blood products |
US20060263759A1 (en) | 2003-03-06 | 2006-11-23 | Odilio Alves-Filho | Dried blood plasma product |
US8492081B2 (en) | 2003-05-16 | 2013-07-23 | The University Of North Carolina At Chapel Hill | Aldehyde-fixed, dried platelets with covalently attached exogenous active agent and method of making thereof |
US7249880B2 (en) | 2003-10-14 | 2007-07-31 | Advanced Technology Materials, Inc. | Flexible mixing bag for mixing solids, liquids and gases |
US8013022B2 (en) * | 2003-12-08 | 2011-09-06 | Deangelo Joseph | Stabilized products, process and devices for preparing same |
US8512754B2 (en) | 2003-12-08 | 2013-08-20 | David Needham | Stabilized products, processes and devices for preparing the same |
US7363726B2 (en) * | 2004-01-23 | 2008-04-29 | Zhaolin Wang | Powder formation by atmospheric spray-freeze drying |
US20080206293A1 (en) | 2004-02-25 | 2008-08-28 | Quick-Med Technologies, Inc. | Absorbent substrate with a non-leaching antimicrobial activity and a controlled-release bioactive agent. |
US9469835B2 (en) * | 2004-06-02 | 2016-10-18 | Victor Bronshtein | Preservation by vaporization |
WO2006000422A1 (en) | 2004-06-29 | 2006-01-05 | Baxter International Inc. | Method for the bulk production of a lyophilisate of a mafosfamide-lysine salt with high storage stability |
US8053248B2 (en) * | 2004-08-13 | 2011-11-08 | The United States Of America As Represented By The Secretary Of The Army | Support system for flexible lyophilization containers |
US20080119818A1 (en) * | 2004-08-13 | 2008-05-22 | Irina Bakaltcheva | Support System for Flexible Lyophilization Containers |
WO2006028648A2 (en) | 2004-08-13 | 2006-03-16 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Support system for flexible lyophilization containers |
US7931919B2 (en) | 2005-08-12 | 2011-04-26 | The United States Of America As Represented By The Secretary Of The Army | Method of producing glycine-stabilized, lyophilized plasma |
WO2007104760A2 (en) | 2006-03-14 | 2007-09-20 | Johannes-Gutenberg-Universität Mainz | Plasma lyophilisate |
US7966746B2 (en) | 2006-04-24 | 2011-06-28 | Medical Instill Technologies, LLC | Needle penetrable and laser resealable lyophilization method |
US7473246B2 (en) | 2006-06-22 | 2009-01-06 | Baxter International Inc. | Medicant reconstitution container and system |
US20080249499A1 (en) | 2006-06-22 | 2008-10-09 | Baxter International Inc. | Medicant delivery system |
US8097403B2 (en) | 2006-12-14 | 2012-01-17 | Cellphire, Inc. | Freeze-dried platelets, method of making and method of use as a diagnostic agent |
US7618406B2 (en) | 2007-01-22 | 2009-11-17 | Baxter International, Inc. | Break seal before access dual chamber bag |
US8235965B2 (en) | 2007-01-22 | 2012-08-07 | Baxter International, Inc. | Embedded access dual chamber bag |
EP2431024A1 (en) * | 2007-02-15 | 2012-03-21 | Octapharma AG | Method for stabilising blood plasma contents in a lyophilisate |
US8518452B2 (en) * | 2007-02-15 | 2013-08-27 | Octapharma Ag | Method for stabilizing blood plasma components in a lyophilizate using carbon dioxide and phosphoric acid |
EP1958618A1 (en) | 2007-02-15 | 2008-08-20 | Octapharma AG | Method for freeze-drying with optimum reconstitution of biopolymers |
US20100159023A1 (en) * | 2007-02-15 | 2010-06-24 | Kim Bjornstrup | Method for stabilising blood plasma components in a lyophilisate |
WO2008115548A2 (en) | 2007-03-19 | 2008-09-25 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US7776022B2 (en) * | 2007-03-19 | 2010-08-17 | Hemcon Medical Technologies | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US8449520B2 (en) | 2007-03-19 | 2013-05-28 | HemCon Medical Technologies Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US20090223080A1 (en) | 2007-03-19 | 2009-09-10 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US20090113753A1 (en) | 2007-03-19 | 2009-05-07 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US20090107001A1 (en) | 2007-03-19 | 2009-04-30 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US20080234653A1 (en) | 2007-03-19 | 2008-09-25 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US20080234654A1 (en) * | 2007-03-19 | 2008-09-25 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
WO2008130602A1 (en) | 2007-04-19 | 2008-10-30 | E. I. Du Pont De Nemours And Company | Container for freeze-drying |
US20080256822A1 (en) | 2007-04-19 | 2008-10-23 | Hiroko Suzuki | Container for freeze-drying |
US8858681B2 (en) | 2007-04-23 | 2014-10-14 | W. L. Gore & Associates, Inc. | Patterned porous venting materials |
JP2014028661A (en) | 2007-04-23 | 2014-02-13 | Gore Enterprise Holdings Inc | Patterned porous venting materials |
US8491178B2 (en) | 2007-06-21 | 2013-07-23 | Gen-Probe Incorporated | Instruments and methods for mixing the contents of a detection chamber |
US8603063B2 (en) | 2007-08-01 | 2013-12-10 | Rexam Healthcare Packaging Inc. | Multilayer plastic container and method of storing lyophilized products |
US20090036862A1 (en) | 2007-08-01 | 2009-02-05 | Owens-Ilinois Healthcare Packaging Inc. | Multilayer plastic container and method of storing lyophilized products |
US8372343B2 (en) | 2007-12-07 | 2013-02-12 | Sheldon Goldstein | Multiple coagulation test cartridge and method of using same |
US9161527B2 (en) | 2007-12-21 | 2015-10-20 | Sartorius Stedim North America Inc. | Systems and methods for freezing, storing and thawing biopharmaceutical materials |
US8516714B2 (en) | 2008-01-21 | 2013-08-27 | Intervet International B.V. | Method for lyophilising particles having a pharmaceutical compound contained therein and a pharmaceutical pack containing such particles |
US20110114524A1 (en) | 2008-06-23 | 2011-05-19 | Bio-Products & Bio-Engineering Ag | Storage-stable, functionally intact fibrinogen |
US20090324929A1 (en) | 2008-06-25 | 2009-12-31 | Keiichi Yamakawa | Composite Membrane and Moisture Adjustment Module Using Same |
WO2010019217A1 (en) | 2008-08-15 | 2010-02-18 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US20110144613A1 (en) | 2008-08-15 | 2011-06-16 | Hemcon Medical Technologies, Inc. | Apparatus and Methods for Making, Storing, and Administering Freeze-Dried Materials Such as Freeze-Dried Plasma |
US20100049156A1 (en) | 2008-08-19 | 2010-02-25 | Drk-Blutspendedienst West Ggmbh | Non-collapsible and non-foldable container for lyophilization of a product |
US8057872B2 (en) | 2008-08-26 | 2011-11-15 | E. I. Du Pont De Nemours And Company | Gas permeable membranes |
WO2010033169A1 (en) | 2008-09-16 | 2010-03-25 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
US20110282325A1 (en) | 2009-01-26 | 2011-11-17 | Ore-gon Biomedical Engineering Institute | Dehydrated plasma kit |
WO2010093429A1 (en) | 2009-02-13 | 2010-08-19 | Hemcon Medical Technologies, Inc. | Apparatus and methods for making, storing, and administering freeze-dried materials such freeze-dried plasma |
US20160375184A1 (en) | 2009-12-22 | 2016-12-29 | Smith & Nephew, Inc. | Apparatuses and methods for negative pressure wound therapy |
US20110183311A1 (en) | 2010-01-27 | 2011-07-28 | David Ho | Dry platelet preparations for use in diagnostics |
US20170259186A1 (en) | 2010-10-29 | 2017-09-14 | Velico Medical, Inc. | Spray drier assembly for automated spray drying |
US20120231485A1 (en) | 2011-03-08 | 2012-09-13 | Oenundarson Pall Torfi | Method for monitoring anticoagulant therapy |
EP2729932A1 (en) | 2011-07-07 | 2014-05-14 | Drexel University | Multi-touch piano keyboard |
WO2013062479A1 (en) | 2011-10-28 | 2013-05-02 | Glycorex Transplantation Ab | A method for extracorporeal elimination of one or more components from blood |
US20140287643A1 (en) | 2011-11-01 | 2014-09-25 | W. L. Gore & Associates, Co., Ltd. | Laminated cloth |
US9046303B2 (en) | 2011-11-30 | 2015-06-02 | Sanwa Engineering Co., Ltd. | Freeze-drying method and apparatus for the same |
US20130326899A1 (en) | 2011-11-30 | 2013-12-12 | Shunichi Yagi | Freeze-drying method and apparatus for the same |
WO2014033228A1 (en) | 2012-08-31 | 2014-03-06 | Flexiways Sprl | Flexible container for transporting products such as biocides |
US20140178513A1 (en) * | 2012-12-23 | 2014-06-26 | Robert Richard Matthews | Non ionic/electrolyte, liquid/gaseous, mechanically refined/nanoparticle dispersion Building Materials/High Wear-Heat Resistant Part Brushes, Windings, Battery Cells, Brake Pads, Die Cast Molding, Refrigeration, Polarized/Integrated Optical, Spectrometric Processors, Central Processor Unit Processors, Electronic Storage Media, Analogous Series/Parallel Circuit Generators/Transceivers, Particulate Matter PM Carbonaceous-Polyamide, Crystalline Silica, and Cellulosic Filament Extraction/Miners Suit |
US20140212895A1 (en) | 2013-01-25 | 2014-07-31 | Xcell Biosciences, Inc. | Cancer Analysis System |
US20140360891A1 (en) | 2013-03-12 | 2014-12-11 | Bret E. Kline | System and method for using adsorbent/absorbent in loading, storing, delivering, and retrieving gases, fluids, and liquids |
US20140259724A1 (en) | 2013-03-13 | 2014-09-18 | Hemcon Medical Technologies, Inc. | Low Aspect Ratio Staged Closure Devices, Systems, and Methods for Freeze-Drying, Storing, Reconstituting, and Administering Lyophilized Plasma |
WO2014165222A1 (en) | 2013-03-13 | 2014-10-09 | Lyp Sciences, Inc. | Low aspect ratio staged closure devices and methods for freeze-drying, storing, reconstituting and administering lyophilized plasma |
US9561893B2 (en) * | 2013-12-05 | 2017-02-07 | Vascular Solutions, Inc. | System and method for freeze-drying and packaging |
US10377520B2 (en) * | 2013-12-05 | 2019-08-13 | Teleflex Innovations S.A.R.L. | System and method for freeze-drying and packaging |
US20150158652A1 (en) * | 2013-12-05 | 2015-06-11 | Vascular Solutions, Inc. | System and method for freeze-drying and packaging |
US20170113824A1 (en) | 2013-12-05 | 2017-04-27 | Vascular Solutions, Inc. | System and method for freeze-drying and packaging |
US9863701B2 (en) * | 2013-12-19 | 2018-01-09 | Aerosol Therapeutics, LLC | Compositions and methods for atmospheric spray freeze drying |
US20150354894A1 (en) * | 2014-06-09 | 2015-12-10 | Terumo Bct, Inc. | Lyophilization |
WO2015191599A2 (en) | 2014-06-09 | 2015-12-17 | Terumo Bct, Inc. | Lyophilization |
US9863699B2 (en) * | 2014-06-09 | 2018-01-09 | Terumo Bct, Inc. | Lyophilization |
US20180128544A1 (en) | 2014-06-09 | 2018-05-10 | Terumo Bct, Inc. | Lyophilization |
US10539367B2 (en) | 2014-06-09 | 2020-01-21 | Terumo Bct, Inc. | Lyophilization |
US9561184B2 (en) | 2014-09-19 | 2017-02-07 | Velico Medical, Inc. | Methods and systems for multi-stage drying of plasma |
US20170100339A1 (en) | 2014-09-19 | 2017-04-13 | Velico Medical, Inc. | Formulations and methods for contemporaneous stabilization of active proteins during spray drying and storage |
US9545379B2 (en) | 2014-09-19 | 2017-01-17 | Velico Medical, Inc. | Formulations and methods for contemporaneous stabilization of active proteins during spray drying and storage |
US20160084572A1 (en) | 2014-09-19 | 2016-03-24 | Velico Medical, Inc. | Process control methods for obtaining and maintaining a desired moisture content of spray dried plasma |
US20170203871A1 (en) | 2016-01-18 | 2017-07-20 | Vascular Solutions, Inc. | System and method for freeze-drying and packaging |
US10492507B2 (en) * | 2017-05-11 | 2019-12-03 | Cornell University | Process for improving shelf-life of fresh cut vegetables and food products produced thereby |
US20190142694A1 (en) | 2017-05-31 | 2019-05-16 | Adienne Pharma & Biotech Sa | Multi Chamber Flexible Bag and Methods of Using Same |
US10507165B2 (en) | 2017-05-31 | 2019-12-17 | Adienne Pharma & Biotech Sa | Multi chamber flexible bag and methods of using same |
WO2019074886A1 (en) * | 2017-10-09 | 2019-04-18 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
US20190106254A1 (en) * | 2017-10-09 | 2019-04-11 | Terumo Bct Biotechnologies, Llc | Lyophilization Container And Method Of Using Same |
Non-Patent Citations (10)
Title |
---|
Cannon, Jeremy W. M.D., "Prehospital Damage-Control Resuscitation", The New England Journal of Medicine, Jul. 26, 2018, pp. 387-388. |
Cherry, Chris, "Containment systems for freeze-drying," ISL-FD, Sep. 7, 2015. |
Cherry, Christopher Lee Albert, "Development of Novel Containment Systems for Freeze-Drying," a thesis submitted to Cardiff Metropolitan University, Apr. 10, 2013. |
Glassberg et al, "Freeze-dried Plasma at the Point of Injury: from Concept to Doctrine", SHOCK, Dec. 2013, vol. 40, No. 6, pp. 444-450. |
International Search Report and Written Opinion, PCT/US2018/054943, dated Jan. 25, 2019. |
Pan et al, "Study of Banana Dehydration Using Sequential Infrared Radiation Heating and Freeze-Drying", LWT-Food Science and Technology, 2008 v. 41, pp. 1944-1951. |
Pan et al, "Study of Banana Dehydration Using Sequential Infrared Radiation Heating and Freeze-Drying", LWT—Food Science and Technology, 2008 v. 41, pp. 1944-1951. |
Soares, Jeffrey M., "Saving Lives with Freeze-dried Plasma", The United States Army, Nov. 27, 2017, pp. 1-5. https://www.army.mil/article/197409. |
Sperry et al, "Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock", The New England Journal of Medicine, Jul. 26, 2018, pp. 315-326. |
US 8,359,766 B2, 01/2013, Hubbard, Jr. et al. (withdrawn) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11067336B2 (en) * | 2014-06-09 | 2021-07-20 | Terumo Bct, Inc. | Lyophilization |
US11806431B2 (en) | 2014-09-19 | 2023-11-07 | Velico Medical, Inc. | Formulations and methods for contemporaneous stabilization of active proteins during spray drying and storage |
US11377276B2 (en) * | 2016-08-05 | 2022-07-05 | Bachem Holding Ag | Drying container |
US11634257B2 (en) * | 2017-10-09 | 2023-04-25 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
US20210396467A1 (en) * | 2018-09-27 | 2021-12-23 | Maat Pharma | Lyophilisation container |
US11674751B2 (en) * | 2018-09-27 | 2023-06-13 | Maat Pharma | Lyophilisation container |
US11965178B2 (en) | 2018-11-30 | 2024-04-23 | Cellphire, Inc. | Platelets loaded with anti-cancer agents |
US11767511B2 (en) | 2018-11-30 | 2023-09-26 | Cellphire, Inc. | Platelets as delivery agents |
US11740019B2 (en) | 2019-03-14 | 2023-08-29 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
US11815311B2 (en) | 2019-03-14 | 2023-11-14 | Terumo Bct Biotechnologies, Llc | Lyophilization container fill fixture, system and method of use |
US11609043B2 (en) | 2019-03-14 | 2023-03-21 | Terumo Bct Biotechnologies, Llc | Lyophilization container fill fixture, system and method of use |
US20230086359A1 (en) * | 2019-03-14 | 2023-03-23 | Terumo Bct Biotechnologies, Llc | Multi-Part Lyophilization Container And Method Of Use |
US11609042B2 (en) * | 2019-03-14 | 2023-03-21 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
US11747082B2 (en) * | 2019-03-14 | 2023-09-05 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
US11604026B2 (en) * | 2019-03-14 | 2023-03-14 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
US11752468B2 (en) | 2019-05-03 | 2023-09-12 | Cellphire, Inc. | Materials and methods for producing blood products |
US11529587B2 (en) | 2019-05-03 | 2022-12-20 | Cellphire, Inc. | Materials and methods for producing blood products |
US11813572B2 (en) | 2019-05-03 | 2023-11-14 | Cellphire, Inc. | Materials and methods for producing blood products |
US11701388B2 (en) | 2019-08-16 | 2023-07-18 | Cellphire, Inc. | Thrombosomes as an antiplatelet agent reversal agent |
US11903971B2 (en) | 2020-02-04 | 2024-02-20 | Cellphire, Inc. | Treatment of von Willebrand disease |
US20220340961A1 (en) * | 2021-04-27 | 2022-10-27 | Enplas Corporation | Freeze-dried structure and producing method thereof |
US11841189B1 (en) | 2022-09-15 | 2023-12-12 | Velico Medical, Inc. | Disposable for a spray drying system |
US11913723B1 (en) | 2022-09-15 | 2024-02-27 | Velico Medical, Inc. | Baffle plate used in a disposable for a spray drying system |
US11913722B1 (en) | 2022-09-15 | 2024-02-27 | Velico Medical, Inc. | Rapid spray drying system |
US11975274B2 (en) | 2022-09-15 | 2024-05-07 | Velico Medical, Inc. | Blood plasma product |
US11994343B2 (en) | 2023-07-11 | 2024-05-28 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
Also Published As
Publication number | Publication date |
---|---|
CN111295094A (en) | 2020-06-16 |
US20210016943A1 (en) | 2021-01-21 |
CA3078625A1 (en) | 2019-04-18 |
JP2021500919A (en) | 2021-01-14 |
US11634257B2 (en) | 2023-04-25 |
EP3694322A1 (en) | 2020-08-19 |
US20190106254A1 (en) | 2019-04-11 |
JP2022119803A (en) | 2022-08-17 |
CA3078625C (en) | 2023-01-17 |
JP7227417B2 (en) | 2023-02-21 |
WO2019074886A1 (en) | 2019-04-18 |
JP7110360B2 (en) | 2022-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11634257B2 (en) | Lyophilization container and method of using same | |
US11747082B2 (en) | Multi-part lyophilization container and method of use | |
US11279510B2 (en) | System and method for freeze-drying and packaging | |
US6517526B1 (en) | Container for lyophilizing biological products | |
US10806665B2 (en) | System and method for freeze-drying and packaging | |
US4973327A (en) | Blood bag for lyophilization | |
US7198150B1 (en) | Device and method for hydrating and rehydrating orthopedic graft materials | |
JP2023130377A (en) | Multi-functional cryogenic storage vessel | |
US11994343B2 (en) | Multi-part lyophilization container and method of use | |
RU2740839C1 (en) | Container for lyophilisation and transfusion of hemocomponents | |
RU2808342C1 (en) | Lyophilization container and method of using it |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
AS | Assignment |
Owner name: TERUMO BCT BIOTECHNOLOGIES, LLC, COLORADO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WEIMER, KIRK L.;JOHNSON, NATE T.;HLAVINKA, DENNIS J.;SIGNING DATES FROM 20181128 TO 20181203;REEL/FRAME:047739/0654 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
AS | Assignment |
Owner name: TERUMO BCT BIOTECHNOLOGIES, LLC, COLORADO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PARAKININKAS, KESTAS P.;REEL/FRAME:048407/0375 Effective date: 20190221 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |